Attachment: 8-K/A


EX-23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-262566) of TerrAscend Corp. of our auditor’s report dated May 23, 2022 relating to the consolidated financial statements of Gage Growth Corp. as at December 31, 2021 and for the year then ended December 31, 2021, which appears in this Current Report on Form 8-K/A.

 

/s/ MNP LLP

Chartered Professional Accountants

Licensed Public Accountants

May 24, 2022

Waterloo, Canada



EX-99.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gage Growth Corp.

Consolidated Financial Statements

For the year ended December 31, 2021

(In United States Dollars)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Gage Growth Corp.

Consolidated Balance Sheets

As of December 31, 2021

(Expressed in United States Dollars, unless stated otherwise)

 

 

 

 

December 31, 2021

 

 

 

$

 

Assets

 

 

 

Current

 

 

 

Cash and cash equivalents

 

 

42,901,079

 

Restricted cash

 

 

1,800,284

 

Marketable securities

 

 

565,029

 

Accounts receivable, net

 

 

7,700,430

 

Prepaids and other current assets

 

 

2,133,609

 

Inventory

 

 

17,639,001

 

 

 

 

72,739,432

 

Non-current assets

 

 

 

Property and equipment, net

 

 

68,473,337

 

Operating right of use assets

 

 

2,316,794

 

Deposits

 

 

1,541,007

 

Intangible assets, net

 

 

8,813,810

 

Investments

 

 

2,294,257

 

 

 

 

83,439,205

 

 

 

 

156,178,637

 

Liabilities

 

 

 

Current

 

 

 

Accounts payable and accrued liabilities

 

 

33,621,918

 

Corporate income tax payable

 

 

4,419,139

 

Operating lease liability

 

 

439,784

 

Property purchase payable

 

 

2,665,341

 

Deferred revenue

 

 

582,792

 

Loans payable

 

 

55,649,482

 

Debentures payable

 

 

2,804,030

 

Financing liability

 

 

688,984

 

Other current liabilities

 

 

107,238

 

 

 

 

100,978,708

 

Non-current liabilities

 

 

 

Financing liability

 

 

12,235,097

 

Operating lease liability

 

 

2,037,189

 

Property purchase payable

 

 

3,822,909

 

Loans payable

 

 

5,198,220

 

Warrant liability

 

 

17,230,055

 

Deferred tax liabilities

 

 

 

Other non-current liabilities

 

 

138,379

 

 

 

 

40,661,849

 

 

 

 

141,640,557

 

 

 

 

 

Shareholders' Equity

 

 

 

Subordinate voting shares, without par value, unlimited authorized, 138,528,663 shares issued as of December 31, 2021

 

 

 

Super Voting Shares, without par value, unlimited authorized, 1,500,000 issued as of December 31, 2021

 

 

 

Exchangeable units, without par value, 1,500,000 authorized and issued as of December 31, 2021

 

 

 

Additional paid-in-capital

 

 

171,196,764

 

Accumulated deficit

 

 

(93,684,699

)

Accumulated other comprehensive income

 

 

2,807,090

 

 

 

 

80,319,155

 

Non-controlling interest

 

 

(65,781,075

)

Total shareholders' equity

 

 

14,538,080

 

 

 

 

156,178,637

 

The accompanying notes are an integral part of these consolidated financial statements.

1


Gage Growth Corp.

Consolidated Statements of Operations and Comprehensive Loss

For the year ended December 31, 2021

(Expressed In United States Dollars, unless stated otherwise)

 

 

 

 

 

For year ended Dec 31,

 

 

 

 

2021

 

 

 

 

 

 

Revenue

 

 

 

91,499,767

 

Cost of sales

 

 

 

(62,100,782

)

Gross Profit

 

 

 

29,398,985

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

General administration

 

 

 

49,024,546

 

Sales and marketing

 

 

 

7,089,387

 

Litigation Expense

 

 

 

2,700,000

 

Depreciation and amortization

 

 

 

1,683,059

 

Operating lease expense

 

 

 

508,939

 

Impairment loss

 

 

 

2,635,486

 

Loss on disposal of finance lease

 

 

 

1,043,913

 

 

 

 

 

64,685,330

 

 

 

 

 

 

Loss from operations

 

 

 

(35,286,345

)

Other (income) expenses

 

 

 

 

Finance expense

 

 

 

3,510,414

 

Unrealized and realized foreign exchange loss (gain)

 

 

 

(261,684

)

Change in fair value of marketable securities

 

 

 

466,520

 

Change in fair value of investments

 

 

 

2,720,294

 

Gain on fair value of warrants

 

 

 

(6,231,316

)

Loss before taxes

 

 

 

(35,490,573

)

Income tax expense (recovery)

 

 

 

 

Current

 

 

 

9,955,469

 

Deferred

 

 

 

(1,117,088

)

 

 

 

 

 

Net loss for the period

 

 

 

(44,328,954

)

 

 

 

 

 

Net loss attributable to subordinate shareholders

 

 

 

(18,580,585

)

Net loss attributable to non-controlling interest

 

 

 

(25,748,369

)

 

 

 

 

(44,328,954

)

Other comprehensive (loss) income ("OCI")

 

 

 

 

 

 

 

 

 

Items that will not be reclassified to profit or loss

 

 

 

 

Unrealized foreign currency translation gain

 

 

 

765,020

 

 

 

 

 

 

Comprehensive loss for the period

 

 

 

(43,563,934

)

 

 

 

 

 

Comprehensive loss attributable to subordinate shareholders of the Company

 

 

 

(18,580,585

)

Comprehensive loss attributable to non-controlling interest

 

 

 

(25,748,369

)

 

 

 

 

(44,328,954

)

 

 

 

 

 

Basic and Diluted net loss per share

 

 

 

(0.14

)

Weighted-average number of shares outstanding - basic and diluted

 

 

 

137,474,219

 

The accompanying notes are an integral part of these consolidated financial statements.

2


Gage Growth Corp.

Consolidated Statements of Changes in Shareholders’ Equity

For the year ended December 31, 2021

(Expressed in United States Dollars, unless stated otherwise)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of
Subordinate
Voting
Shares

 

 

 

Number of Super Voting Shares

 

 

 

 

Exchangeable unit shares

 

 

Additional paid in capital

 

 

Accumulated other comprehensive income

 

 

Accumulated deficit

 

Total

 

Non-controlling interest

 

 

Attributable to subordinate shareholders

 

Balance at December 31, 2020

 

 

131,649,944

 

 

 

 

1,500,000

 

 

 

 

 

1,500,000

 

 

 

156,329,152

 

 

 

2,042,070

 

 

 

(75,104,114

)

 

83,267,108

 

 

(40,032,706

)

 

 

43,234,402

 

Share-based payments

 

 

 

1,770,000

 

 

 

 

 

 

 

 

 

 

 

 

2,996,000

 

 

 

 

 

 

 

 

2,996,000

 

 

 

 

 

2,996,000

 

Share-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,498,788

 

 

 

 

 

 

 

 

3,498,788

 

 

 

 

 

3,498,788

 

Reg. A Financing

 

 

 

4,614,255

 

 

 

 

 

 

 

 

 

 

 

 

8,116,089

 

 

 

 

 

 

 

 

8,116,089

 

 

 

 

 

8,116,089

 

Transaction costs deducted from Reg. A Financing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(673,507

)

 

 

 

 

 

 

 

(673,507

)

 

 

 

 

(673,507

)

Exercise of share options

 

 

 

434,164

 

 

 

 

 

 

 

 

 

 

 

 

858,474

 

 

 

 

 

 

 

 

858,474

 

 

 

 

 

858,474

 

Exercise of warrants

 

 

 

60,300

 

 

 

 

 

 

 

 

 

 

 

 

71,768

 

 

 

 

 

 

 

 

71,768

 

 

 

 

 

71,768

 

Foreign currency translation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

765,020

 

 

 

 

 

765,020

 

 

 

 

 

765,020

 

Net loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(18,580,585

)

 

(18,580,585

)

 

(25,748,369

)

 

 

(44,328,954

)

Balance at December 31, 2021

 

 

138,528,663

 

 

 

 

1,500,000

 

 

 

 

 

1,500,000

 

 

 

171,196,764

 

 

 

2,807,090

 

 

 

(93,684,699

)

 

80,319,155

 

 

(65,781,075

)

 

 

14,538,080

 

The accompanying notes are an integral part of these consolidated financial statements.

3


Gage Growth Corp.

Consolidated Statements of Cash Flows

For the year ended December 31, 2021

(Expressed in United States Dollars, unless stated otherwise)

 

 

 

Year ended December 31,

 

 

 

2021

 

 

 

$

 

Operating activities

 

 

 

Net loss for the period

 

 

(44,328,954

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities

 

 

 

Depreciation and amortization

 

 

2,509,614

 

Depreciation of right of use assets

 

 

790,343

 

Share-based payments

 

 

6,492,965

 

Allowance for doubtful accounts

 

 

692,447

 

Non-cash write downs of inventory

 

 

1,043,133

 

Non-cash litigation expense

 

 

2,700,000

 

Unrealized gain on marketable securities and convertible debenture

 

 

466,520

 

(Gain) loss on foreign exchange

 

 

(261,684

)

Change in fair value of investments

 

 

2,720,294

 

Deferred tax (recovery) expense

 

 

(1,117,087

)

Interest expense

 

 

1,992,933

 

Impairment expense

 

 

2,635,486

 

Loss on disposal of finance leases

 

 

1,043,913

 

Gain on financial instruments

 

 

(6,658,670

)

Changes in operating assets and liabilities

 

 

 

Accounts receivable

 

 

(8,141,034

)

Prepaids and other current assets

 

 

(844,288

)

Inventory

 

 

(11,537,638

)

Accounts payable and accrued liabilities

 

 

11,302,393

 

Operating lease liability

 

 

824,846

 

Current tax payable

 

 

3,095,026

 

Deferred revenue

 

 

186,926

 

Other

 

 

302,952

 

Net cash used in operating activities

 

 

(34,089,565

)

 

 

 

 

Investing activities

 

 

 

Investment in convertible debentures

 

 

(401,966

)

Addition of intangible assets

 

 

(2,501,274

)

Proceeds from sale of investment

 

 

1,779,582

 

Purchase of property, plant, and equipment

 

 

(23,840,192

)

Net cash used in investing activities

 

 

(24,963,850

)

 

 

 

 

Financing activities

 

 

 

Net proceeds from Reg. A financing

 

 

7,442,582

 

Notes payable payments

 

 

(1,062,700

)

Share options exercised

 

 

860,296

 

Warrants exercised

 

 

71,769

 

Repayment of debenture payable

 

 

(289,126

)

Repayments of property purchase payable

 

 

(847,370

)

Lease liability payments

 

 

(2,044,078

)

Proceeds from Credit facility

 

 

53,419,895

 

Net cash provided by financing activities

 

 

57,551,268

 

 

 

 

 

Increase (decrease) in cash, cash equivalents, and restricted cash

 

 

(1,502,147

)

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

 

747,928

 

Cash, cash equivalents, and restricted cash at beginning of period

 

 

45,455,583

 

Cash, cash equivalents, and restricted cash at end of period

 

 

44,701,364

 

Supplemental Cash Flow Information

 

 

 

 

 

 

 

Income Taxes Paid

 

 

5,041,348

 

Interest Paid

 

 

1,517,481

 

Amount included in restricted cash

 

 

1,800,284

 

 

 

 

 

Non-cash transactions

 

 

 

 

 

 

 

Promissory notes issued as consideration for asset purchase

 

 

4,255,408

 

 

4


Gage Growth Corp.

Property purchase payables assumed in consideration for land and buildings

 

 

6,990,116

 

Warrants for intangibles

 

 

2,018,185

 

Options issued for property

 

 

327,250

 

Accrued capital purchases

 

 

6,379,511

 

Capital purchases through property purchase payable

 

 

6,990,116

 

Marketable securities received in sale of investments

 

 

1,272,553

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

5


Gage Growth Corp.

Notes to the Consolidated Financial Statements

For the year ended December 31, 2021

(Expressed in United States Dollars, unless stated otherwise)

 

1.
INCORPORATION AND NATURE OF BUSINESS

 

Wolverine Partners Corp. (“Wolverine”) was incorporated on November 22, 2017, under the Ontario Business Corporations Act. On March 11, 2019, the Company filed an amendment to the Articles of Incorporation whereby the Company re-designated the existing class of common shares as subordinate voting shares (“Subordinate Voting Shares”) and is authorized to issue an unlimited number of super voting shares (“Super Voting Shares”) and proportionate voting shares (“Proportionate Voting Shares”) (Note 15). On October 9, 2020, Wolverine filed Articles of Amendment changing the name of the Corporation to Gage Growth Corp (“Gage”, the “Corporation”, or the “Company”). The principal activities of the Company are providing branding and crucial support services to affiliated licensed operators that produce, distribute, and sell cannabis and cannabis-related products in the State of Michigan.

 

The Company was listed on the Canadian Securities Exchange effective April 6, 2021, having the ticker symbol GAGE. The registered office of the Company is located at Suite 400, 77 King Street West Toronto –Dominion Centre, Toronto, Ontario M5K 0A1.

 

On March 10, 2022, the Company was purchased by TerrAscend Corp. ("TerrAscend"). As part of the transaction, Gage shareholders received 51,349,978 TerrAscend common shares, 13,504,500 exchangeable units, 5,221,542 replacement stock options, and 282,023 replacement warrants.

2.
BASIS OF PRESENTATION AND STATEMENT OF COMPLIANCE

 

Statement of compliance

 

These consolidated financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

Principles of consolidation

 

These consolidated financial statements include the accounts of the Company and its controlled subsidiaries. For financial reporting purposes, the Company consolidates legal entities in which it holds a controlling financial interest. The Company has a two-tier consolidation model: one focused on voting rights (the voting interest model) and the second focused on a qualitative analysis of power over significant activities and exposure to potentially significant losses or benefits (the variable interest model). All entities are first

6


Gage Growth Corp.

evaluated to determine whether they are variable interest entities (“VIE”). If an entity is determined not to be a VIE, it is assessed on the basis of voting and other decision-making rights under the voting interest model.

 

The accounts of all subsidiaries are prepared for the same reporting period using consistent accounting policies. All intercompany balances and transactions are eliminated on consolidation. The table below lists the Company, its controlled subsidiaries, and the ownership interests in each:

 

Name of Company

 

Place of Incorporation /
Operation

 

Functional
Currency

 

Ownership
%

Gage Growth Corp.

 

Canada

 

CAD

 

100%

Gage Innovations Corp.

 

Canada

 

CAD

 

100%

Cookies Retail Canada Corp.

 

Canada

 

CAD

 

80%

Rivers Innovation, Inc.

 

United States

 

USD

 

100%

Rivers Innovations US South LLC

 

United States

 

USD

 

100%

RI SPE LLC

 

United States

 

USD

 

100%

Spartan Partners Corporation

 

United States

 

USD

 

100%

Spartan Partners Holdings, LLC

 

United States

 

USD

 

51.3%

Spartan Partners Services LLC

 

United States

 

USD

 

51.3%

Spartan Partners, Properties LLC

 

United States

 

USD

 

51.3%

Spartan Partners Licensing LLC

 

United States

 

USD

 

51.3%

Mayde US, LLC

 

United States

 

USD

 

51.3%

AEY Holdings, LLC*

 

United States

 

USD

 

0%

AEY Thrive, LLC*

 

United States

 

USD

 

0%

AEY Capital, LLC*

 

United States

 

USD

 

0%

3 State Park, LLC*

 

United States

 

USD

 

0%

Pure Releaf SP Drive, LLC*

 

United States

 

USD

 

0%

RKD Ventures, LLC*

 

United States

 

USD

 

0%

Stadium Ventures, LLC*

 

United States

 

USD

 

0%

Effective February 11, 2021, Spartan Services terminated its services agreement, its license agreement and its membership interest transfer restriction and succession agreement with Buena Vista Real Estate LLC (“Buena Vista”). At the time of such termination, Buena Vista held a local permit for a non-operational provisioning center in Buena Vista, Michigan.

 

On August 1, 2021, Spartan Services signed a Services Agreement with RKD Ventures, LLC ("RKD"). As part of this agreement, Spartan Services effectively gained control over RKD. Consequently, the Company began to consolidate RKD into its financial statements subsequent to the August 1 agreement. At the end of September, AEY Holdings, LLC, finalized a purchase of 51% of the Membership Interests of RKD for $750,000. As RKD's net assets were already consolidated into the Company's financial statements, the Company recorded a corresponding adjustment to the Accumulated deficit to reflect the impact of the consideration paid.

 

On December 31, 2021, AEY Holdings, LLC (“AEY Holdings”), purchased 100% of the stock in Stadium Ventures, LLC (“Stadium Ventures”). As the Company controls AEY Holdings through previously existing agreements, the Company gained control of Stadium Ventures through this acquisition. The Company assessed this transaction to determine whether this represented a business acquisition in accordance with ASC 805. On assessment, the Company found that Stadium Ventures did not represent a business in accordance with ASC 805 'Business Combinations', as the entity at the time of acquisition did not have a substantive process with the ability to create outputs. Consequently, this acquisition was accounted for as an asset acquisition, with consideration transferred allocated to the assets acquired, which primarily consisted of an adult-use cannabis license and an operating lease asset.

 

*The Company through its subsidiaries, entered into Membership Interest Transfer Restriction and Succession Agreement and Services Agreements with its affiliated licensing companies which prevent the licensing companies from taking certain actions or omitting to take certain actions where to do so would be contrary to the expected economic benefits that the Company expects to derive from the relationship with the licensing companies. The Company includes these entities in its consolidation but has allocated their net loss and comprehensive loss in the Company’s Consolidated Statements of operations and Comprehensive Loss to net loss and comprehensive loss attributable to non-controlling interest.
 

3.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

a) Functional and presentation currency


The functional currency of the Company and its Canadian subsidiaries is Canadian dollars (“C$”). The functional currency of the Company’s US subsidiaries is the US dollar (“USD”). The Company’s presentation currency is in USD. All amounts are presented in USD unless otherwise specified. Where the functional currency is different from the presentation currency, assets and liabilities have

7


Gage Growth Corp.

been translated using the exchange rate at the year end, and income, expenses, and cash flow items are translated using the rate that approximates the exchange rates at the dates of the transactions (the average for the period). All resulting exchange rate differences are recorded in accumulated other comprehensive (loss) income. Exchange differences arising on the retranslation of unsettled monetary assets and liabilities are recognized immediately in net loss. Non-monetary assets and liabilities are translated using historical exchange rates. Nonmonetary assets and liabilities measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value is determined. Transactions entered into in a currency other than the currency of the primary economic environment in which the Company or its subsidiaries operates (their "functional currency") are recorded at the rates prevailing when the transactions occur except depreciation and amortization which are translated at the rates of exchange applicable to the related assets. Foreign currency monetary assets and liabilities are translated at current rates of exchange with the resulting gain or losses recognized in the consolidated statements of operations and comprehensive loss.
 

b) Cash and cash equivalents


Cash and cash equivalents include cash on hand and other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and subject to an insignificant risk of change in value.

Restricted cash includes any cash held that are restricted through legal agreements and are not available for general use by the Company.
 

c) Inventory


Inventories of harvested and purchased work-in-process and finished goods are valued at the lower of cost or net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the reasonably predictable costs of completion, disposal and transportation. The direct and indirect costs of inventory include materials, labor and depreciation expense on equipment involved in packaging, labeling and inspection. Amortization of acquired cannabis production licenses are also considered to be indirect costs of inventory. All direct and indirect costs related to inventory are capitalized as they are incurred and they are subsequently recorded within cost of sales on the consolidated statements of operations at the time cannabis is sold.

The Company reviews inventory for obsolete, redundant, and slow-moving goods, and any such inventories are written down to net realizable value.
 

d) Property and equipment and long-lived assets held for sale
 

Property and equipment is measured at cost, including capitalized borrowing costs, less accumulated depreciation and impairment losses. Ordinary repairs and maintenance are expensed as incurred. Depreciation is calculated on a straight-line basis over the estimated useful life of the asset using the following terms:

 

Asset type

 

Depreciation method

 

Depreciation terms

Land

 

No depreciation

 

No term

Building

 

Straight-line

 

15-39 years

Leasehold improvements

 

Straight-line

 

Over term of lease

Machinery and equipment

 

Straight-line

 

7-10 years

Office furniture and equipment

 

Straight-line

 

5-7 years

Computer and software

 

Straight-line

 

3-5 years

Construction in progress

 

No depreciation

 

No term

Right-of-use-assets

 

Straight-line

 

Over term of lease

Vehicles

 

Straight-line

 

3-5 years

 

Construction in process are transferred to the appropriate asset type when available for use and depreciation of the assets commences at that point.

Long-lived assets held for sale are recorded at their estimated fair value less costs to sell. The Company discontinues depreciation on these assets.

An asset’s residual value, useful life and depreciation method are reviewed annually, or when events or circumstances indicate that the current estimate or depreciation method are no longer applicable. Changes are adjusted prospectively if appropriate. Gains and losses on disposal of an asset are determined by comparing the proceeds from disposal with the carrying amount of the items and are recognized in the consolidated statements of operations. If a loss on disposal is expected, such losses are recognized when the assets are reclassified as assets held for sale or when impaired as part of an asset group’s impairment.

The Company evaluates the recoverability of property and equipment and long-lived assets held for sale, whenever events or changes in circumstances indicate that the carrying value of the asset or asset group may not be recoverable. See – Impairment of long-lived

8


Gage Growth Corp.

assets information within this note for detailed information on the Company’s impairment assessment of its property and equipment.
 

e) Leases
 

The Company’s leases are primarily operating leases for corporate offices and retail dispensaries.

The Company’s leases include fixed payments, as well as in some cases, scheduled base rent increases over the term of the lease. Certain leases require variable payments of common area maintenance, operating expenses, and real estate taxes applicable to the property. Variable payments are excluded from the measurements of lease liabilities and are expensed as incurred.

The Company determines if an arrangement is a lease at the inception of the contract. Lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term for those arrangements where there is an identified asset and the contract conveys the right to control its use. The right-of-use (“ROU”) asset is measured at the initial amount of the lease liability, adjusted for lease payments made at or before the lease commencement date, and initial direct costs. For operating leases, right-of-use assets are reduced over the lease term by the straight-line expense recognized, less the amount of accretion of the lease liability determined using the effective interest rate method. Finance leases are included in property and equipment in the Consolidated Balance Sheets.

The Company assigns a discount rate to leases based on its incremental borrowing rate at the time of lease inception. The majority of the Company’s leases do not provide an implicit rate that can be easily determined, and therefore uses its incremental borrowing rate and the information available at the commencement date.

Certain leases include one or more options to renew or terminate the lease at the Company’s discretion. The Company regularly evaluates lease renewal and termination options and, when they are reasonably certain of exercise, includes the renewal or termination option in the lease term.

The Company evaluates its ROU assets for impairment consistent with its impairment of long-lived assets. See – Impairment of long-lived assets information within this note for detailed information on the Company’s impairment assessment of its right-of-use assets.
 

f) Intangible assets
 

Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Amortization is provided on a straight-line basis over the assets’ estimated useful lives, which do not exceed the contractual period, if any. The estimated useful lives, residual values and amortization methods are reviewed annually and any changes in estimates are accounted for prospectively. Licenses relating to cultivation and dispensaries are amortized using a useful life consistent with the property and equipment to which they relate. Brand intangible assets are amortized over 5 years.

The Company does not hold any indefinitely-lived intangible assets or Goodwill.
 

g) Impairment of long-lived assets
 

The Company evaluates the recoverability of long-lived assets, including property and equipment, ROU assets, and definite lived intangible assets, whether events or changes in circumstances indicate that the carrying value of the asset, or asset group, may not be recoverable.

When the Company determines that the carrying value of the long-lived asset may not be recoverable based upon the existence of one or more of the indicators, the assets are assessed for impairment based on the estimate of future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the carrying value of an asset exceeds its estimated future undiscounted cash flows, an impairment loss is recorded for the excess of the asset’s carrying value over its fair value.
 

h) Investments
 

All investments are initially recorded at cost. Management assesses investments for impairment on an annual basis or when events or changes in circumstances indicate that the carrying value of the investment may not be recoverable.
 

i) Revenue recognition
 

Revenue is recognized by the Company in accordance with ASU 2014-09 Revenue from Contracts with Customers (Topic 606). The standard requires sales to be recognized in a manner that depicts the transfer of promised goods or services to a customer and at an amount that reflects the consideration expected to be received in exchange for transferring those goods or services. This is achieved by

9


Gage Growth Corp.

applying the following five steps: i) identify the contract with a customer; ii) identify the performance obligations in the contract; iii) determine the transaction price; iv) allocate the transaction price to the performance obligations in the contract; and v) recognize sales when (or as) the entity satisfies a performance obligation.

Revenues consist of wholesale and retail sales, which are recognized when control of the goods has transferred to the purchaser and the collectability is reasonably assured. For wholesale revenue, this is generally when goods have been shipped, which is also when the performance obligations have been fulfilled under the terms of the related sales contract. Revenue from retail sales of cannabis to customers for a fixed price is recognized when the Company transfers control of the goods to the customer at the point of sale and the customer has accepted and paid for the goods. Sales are recorded net of returns and discounts and incentives. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. All shipping and handling activities are performed before the customers obtain control of products and are accounted for as cost of sales.

From time to time, the Company partakes in sales agreements with suppliers in which it also purchases inventory. As part of the five-step revenue model, the Company assesses whether instances of bulk sales made to suppliers of goods have commercial substance and should be recognized as revenue, or whether they should be assessed under ASC 845 Nonmonetary Transactions.
 

j) Non-controlling interest
 

Non-controlling interest (“NCI”) represents equity interests in consolidated entities that are owned by parties that are not shareholders of the ultimate parent. Non-controlling interest is to be initially measured either at fair value or at the noncontrolling interest’s proportionate share of the recognized amounts of the acquiree’s identifiable net assets.

k) Income taxes
 

Income tax expense, consisting of current and deferred tax expense, is recognized in the consolidated statements of operations. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period-end, adjusted for amendments to tax payable with regard to previous years. Deferred tax assets and liabilities and the related deferred income tax expense or recovery are recognized for deferred tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply when the asset is realized, or the liability settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income (loss) in the period that enactment occurs. A deferred tax asset is recognized to the extent that it is more-likely-than-not that future taxable profits will be available against which the asset can be utilized. To the extent that the Company does not consider it probable that a deferred tax asset will be recovered, the deferred tax asset is reduced. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.
 

l) Share based compensation
 

The Company has a stock option plan in place. The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense on a graded basis over the vesting period. Fair value is measured using the Black-Scholes option pricing model. In estimating fair value, management is required to make certain assumptions and estimates such as the expected life of units, volatility of the Company’s future share price, risk free rates, expected forfeiture and future dividend yields at the initial grant date. Changes in assumptions used to estimate fair value could result in materially different results. Expected forfeitures are estimated at the date of grant, based on historical trends of actual option forfeitures, and subsequently adjusted if further information indicates actual forfeitures may vary from the original estimate. Any revisions are recognized in the consolidated statements of operations and comprehensive loss such that the cumulative expense reflects the revised estimate. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. If the actual forfeiture rate is materially different from management’s estimates, the stock-based compensation expense could be significantly different from what the Company has recorded in the current period.

Upon exercise of stock options and warrants that are classified as equity, any historical fair value in the warrants and share-based compensation reserve is allocated to additional paid in capital. Amounts recorded for expired unexercised stock options and warrants are transferred to deficit in the year of expiration.

 

m) Share capital

 

Subordinate voting shares

Common shares are classified as equity. The proceeds from the exercise of stock options or warrants together with amounts previously allocated to additional paid-in-capital over the vesting periods are recorded as share capital. Incremental costs directly attributable to the issuance of shares are recognized as a deduction from equity.

10


Gage Growth Corp.

 

Equity units

Proceeds received on the issuance of equity units comprised of subordinate voting shares and warrants, such as convertible debentures and warrants, are allocated to common shares and warrants based on the relative fair value method.

 

n) Warrant liability
 

The Company may issue common stock warrants with debt, equity or as a standalone financing instrument that is recorded as either liabilities or equity in accordance with the respective accounting guidance. Warrants recorded as equity are recorded at their relative fair value determined at the issuance date and remeasurement is not required. Warrants recorded as liabilities are recorded at their fair value, within warrant liability on the consolidated balance sheets, and remeasured on each reporting date with changes recorded in the Company's consolidated statements of operations and comprehensive loss.
 

o) Convertible instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

 

Companies are required to bifurcate conversion options from their host instrument and account for them as free-standing derivative financial instruments according to certain criteria. The criteria includes circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under GAAP with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

 

p) Earnings (loss) per share
 

The Company presents basic and diluted earnings (loss) per share data for its ordinary shares. Basic earnings (loss) per share is calculated using the treasury stock method, by dividing the income (loss) attributable to common and proportionate shareholders of the Company by the weighted average number of common and proportionate voting shares outstanding during the period. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings (loss) per share calculations. The Company has the following categories of potentially dilutive common share equivalents: stock options, warrants, and convertible debentures.

In order to determine diluted earnings (loss) per share, it is assumed that any proceeds from the exercise of dilutive instruments would be used to repurchase common shares at the average market price during the period. The Company also considers all outstanding convertible securities, such as the convertible preferred shares, convertible debentures, and outstanding exchangeable shares as if the instruments were converted to the Company’s common stock. During the year ended December 31, 2021, all potentially dilutive shares were excluded from the calculation of diluted earnings per share as their impact would have been anti-dilutive.
 

q) Use of significant estimates and judgements
 

The preparation of the Company’s consolidated financial statements requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.

Management has applied significant estimates and judgements related to the following:
 

i.
Accounts Receivable

11


Gage Growth Corp.

 

For certain wholesale revenue transactions, sales are made to customers under specified credit terms. At inception and at the end of each period, the Company assesses outstanding accounts receivable to determine the accounts receivable, on a customer-by-customer basis that is expected to be collected. At inception, the amounts not expected to be collected are treated as a deduction to revenue. In subsequent periods, amounts considered to be bad debt expense are included in 'General administrative' expenses on the statements of operations and comprehensive loss.

 

ii.
Inventory
 

The net realizable value of inventory represents the estimated selling price in the ordinary course of business less the costs of completion, disposal and transportation. The Company estimates the net realizable value of inventories, taking into account the most reliable evidence available at each reporting date. The determination of net realizable value requires significant judgment, including consideration of factors such as shrinkage, the aging of and future demand for inventory, expected future selling price the Company expects to realize by selling the inventory, and the contractual arrangements with customers. Reserves for excess and obsolete inventory are based upon quantities on hand, projected volumes from demand forecasts and net realizable value. The future realization of these inventories may be affected by market-driven changes that may reduce future selling prices. A change to these assumptions could impact the Company’s inventory valuation and gross profit.

The impact of inventory reserves is reflected in cost of sales.
 

iii.
Revenue recognition
 

From time to time, the Company partakes in sales agreements with suppliers in which it also purchases inventory. As part of the five-step revenue model, the Company assesses whether instances of bulk sales made to suppliers of goods have commercial substance and should be recognized as revenue, or whether they should be assessed under ASC 845 Nonmonetary Transactions, which requires management judgment to determine if the transaction has commercial substance.
 

iv.
Share-based payments
 

In calculating share-based compensation expense, key estimates are used such as, the rate of forfeiture of options granted, the volatility of the Company’s stock price, and the risk-free interest rate.
 

v.
Warrant liability
 

In calculating the fair value of warrants issued, the Company includes key estimates such as the volatility of the Company's stock price and the risk-free interest rate. The Company uses judgment to select methods used and in performing the fair value calculations at the calculations at the initial measurement on issuance as well as for subsequent measurement on a recurring basis.

 

vi.
Income taxes
 

The extent to which deferred tax assets can be recognized is based on an assessment of the probability of the Company generating future taxable income against which the deferred tax assets can be utilized. In addition, significant judgment is required in classifying transactions and assessing probable outcomes of tax positions taken, and in assessing the impact of any legal or economic limits or uncertainties in various tax jurisdictions. Provisions for taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these provisions at the end of the reporting period. It is possible, however, that at some future date, an additional liability could result from audits by taxing authorities. If the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made.
 

vii.
Impairment of long-lived assets
 

The Company evaluates the recoverability of long-lived assets, including property and equipment, ROU assets, and definite lived intangible assets, whether events or changes in circumstances indicate that the carrying value of the asset, or asset group, may not be

12


Gage Growth Corp.

recoverable.

When the Company determines that the carrying value of the long-lived asset may not be recoverable based upon the existence of one or more of the indicators, the assets are assessed for impairment based on the estimate of future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the carrying value of an asset exceeds its estimated future undiscounted cash flows, an impairment loss is recorded for the excess of the asset’s carrying value over its fair value.
 

viii.
Incremental borrowing rates

 

Lease payments are discounted using the rate implicit in the lease if that rate is readily available. If that rate cannot be easily determined, the lessee is required to use its incremental borrowing rate. The incremental borrowing rate is the rate of interest that the Company estimates it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The Company calculates its incremental borrowing rate as the interest rate the Company would pay to borrow funds necessary to obtain an asset of similar value over similar terms taking into consideration the economic factors and the credit risk rating at the commencement date of the lease.
 

ix.
Lease periods

 

The Company's lease terms may include options to extend or terminate the lease and such options are included in the lease term when it is reasonably certain that the Company will exercise these options.

 

x.
Acquisitions

 

The Company evaluates whether any acquisition of an entity represents a business or asset acquisition in accordance with ASC 805. To determine whether the acquired entity meets the definition of a business, the Company first assesses whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, then the acquired entity does not represent a business. If this is not met, then the Company considers whether the acquired entity has an input and substantive process that together significantly contribute to the ability to create outputs. If the acquired entity does not meet this threshold, then the Company will account for the acquisition as an asset acquisition, where the consideration price is applied to the assets acquired. If the acquired entity meets this threshold and is considered a business, in which substantially all identifiable assets, liabilities and contingent liabilities acquired are recorded at the date of acquisition at their respective fair values

 

xi.
Control, joint control, or level of influence
 

When determining the appropriate basis of accounting for the Company’s interests in affiliates, the Company makes judgments about the degree of influence that it exerts directly or through an arrangement over the investees’ relevant activities.
 

r) New standards, amendments and interpretations adopted
 

i.
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to the accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. The Company adopted this standard effective January 1, 2021 and notes that it did not have a material impact on the Company’s consolidated financial statements.
ii.
In January 2020, the FASB issued ASU 2020-01, Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU 2020-01”), which is intended to clarify the interaction of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounting for under Topic 815. The Company adopted this standard January 1, 2021 and notes that it did not have a material impact on the Company’s consolidated financial statements.
iii.
On August 5, 2020, the FASB issued ASU No. 2020-06, Debt- Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, to improve financial reporting associated with accounting for convertible instruments and contracts in an entity’s own equity. The amendments in this Update are effective for public

13


Gage Growth Corp.

business entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company adopted this standard January 1, 2021 and notes that it does not have a material impact on the Company’s consolidated financial statements.
 

s) New standards, amendments, and interpretations not yet adopted
 

i.
In October 2021, the FASB issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805). This ASU requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The ASU is effective for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Adoption of the ASU should be applied prospectively. Early adoption is permitted, including adoption in an interim period. The ASU is currently not expected to have a material impact on the Company’s consolidated financial statements.
4.
ACCOUNTS RECEIVABLE, NET

 

 

 

December 31, 2021

 

Trade receivables

$

 

8,392,877

 

Less: provision for sales returns and expected credit losses

 

 

(692,447

)

Trade receivables, net

$

 

7,700,430

 

Of which

 

 

 

Current

$

 

5,504,855

 

31-90 days

 

 

1,627,500

 

Over 90 days

 

 

1,260,522

 

Less: provision for sales returns and expected credit losses

 

 

(692,447

)

Total trade receivables, net

$

 

7,700,430

 

The following is a roll-forward of the provision for allowances related to trade accounts, receivable for the years ended:

 

 

 

December 31, 2021

 

December 31, 2020

$

 

 

Provision for sales returns

 

 

 

Expected credit losses

 

 

692,447

 

Write-offs charged against provision

 

 

 

Total provision for expected credit losses

$

 

692,447

 

 

5.
INVENTORY

Inventory consists of domestically grown and produced medicinal and adult-use cannabis, concentrates, edibles, vaporizers, and merchandise for distribution. The Company's inventory is comprised of the following items:

 

 

December 31, 2021

 

Work in process

$

 

11,413,219

 

Finished goods

 

 

6,225,782

 

 

$

 

17,639,001

 


During the year ended December 31, 2021, the Company recorded impairment of $1,043,133 associated with the costs of excess and obsolete inventory.

 

6.
PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net, consisted of:

 

14


Gage Growth Corp.

 

 

December 31, 2021

 

Land

$

 

3,051,232

 

Building

 

 

23,333,607

 

Leasehold improvements

 

 

8,291,136

 

Machinery and equipment

 

 

5,436,207

 

Office furniture

 

 

1,245,527

 

Computer and software

 

 

1,323,321

 

Construction in progress

 

 

28,538,123

 

Vehicles

 

 

57,727

 

Assets under finance leases

 

 

452,431

 

Total cost

 

 

71,729,311

 

Less: accumulated depreciation

 

 

(3,255,974

)

Property and equipment, net

$

 

68,473,337

 

 

During the year ended December 31, 2021, the Company capitalized $190,700 of borrowing costs.

Construction in process relates to both cultivation and dispensary facilities not yet completed or otherwise not placed into service.

Depreciation expense was $2,411,108 for the year ended December 31, 2021 ($826,555 included in cost of sales).
 

Asset Specific Impairment

The Company reviews the carrying value of its property and equipment at each reporting period for indicators of impairment. During the year ended December 31, 2021, the Company determined that two specific properties needed to be assessed for impairment as the Company’s operations related to both properties was far below initial cash flow estimates. The Company evaluated the recoverability of the asset to determine whether it would be recoverable. Upon analysis, it was determined that the carrying value of the asset exceeded its estimated future undiscounted cash flows and therefore recorded an impairment loss of $2,635,486 million.

 

7. INTANGIBLE ASSETS, NET

 

Intangible assets consisted of the following:

 

 

At December 31, 2021

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net Carrying Amount

 

Finite lived intangible assets

 

 

 

 

 

 

 

 

 

Licenses

$

 

6,952,849

 

$

 

(88,736

)

$

 

6,864,113

 

Brand intangibles

 

 

2,018,185

 

 

 

(68,488

)

 

 

1,949,697

 

Intangible assets, net

$

 

8,971,034

 

$

 

(157,224

)

$

 

8,813,810

 

 

The gross carrying amount of intangible assets increased $8,784,287 during the year ended December 31, 2021. The increase was mostly due to the purchase of a Cannabis license for the Company’s Ann Arbor location, which was valued at $6,760,686 and is amortized over 5 years. The consideration for the license included a $2,500,000 cash payment and a $4,260,686 note payable.

 

The remaining difference was due to the acquisition of brand intangibles. On July 1, 2021, Spartan Partners Licensing (“SPL”) signed an agreement with KKE Licensing. The IP agreement allows Spartan Partners Licensing and its affiliates the exclusive right to utilize the license and branding of KKE within the state of Michigan. The initial term of the agreement is 5 years from the commencement date, where the commencement date is the earlier of the first day of the month after the first shipment of products under the deal or November 1st. As part of the agreement, SPL pays a royalty fee of 5% on products sold under the agreement. In addition, the Company granted warrants as part of the agreement. The warrants were issued in order to maintain the Company’s exclusive right to utilize KKE’s name and branding within the State of Michigan. In total, 780,727 warrants were determinable and granted as part of the agreement, with 390,364 vesting on July 2nd, 2021, and 390,363 vesting on July 2nd, 2022. In addition, $500,000 worth of warrants will be granted on July 2, 2023 and $500,000 worth of warrants will be granted on July 2, 2024. The number of warrants to be issued will be determined closer to the date of issuance to determine the appropriate number of warrants to issue based on updated share price and volatility information.

 

The Company determined that the exclusive right to KKE’s name and branding represented a warrant liability, and recorded a warrant liability of $2,018,185 corresponding to the acquisition of the brand. Assumptions used in valuation of the KKE warrant liability are disclosed in footnote 22.

15


Gage Growth Corp.

 

Amortization expense was $98,506 for the year ended December 31, 2021.

 

As it relates to intangible assets in-use, the Company is scheduled to record the following amounts in amortization expense over the next five years.

 

At December 31, 2021

 

Gross Carrying Amount

 

2022

$

 

1,811,929

 

2023

 

 

1,817,604

 

2024

 

 

1,812,557

 

2025

 

 

1,777,931

 

2026

 

 

1,593,789

 

 

8. INVESTMENTS

 

(a)
Mass2Media, LLC

On October 8, 2019, pursuant to the acquisition of Rivers Innovations Inc., the Company acquired a 12.5% ownership (on a fully diluted basis) in a private company Mass2Media, LLC, doing business as PX2 Holdings, LLC. The fair value at the date of acquisition was $11,900,000. The Company determined the fair value of this investment based on a calibration discount to the market-based multiple of enterprise value over trailing twelve-month revenue of selected comparable public companies at year-end. The Company elected to value Mass2Media on a cost basis, less impairment recognized in subsequent periods.

On June 28th, 2021, Mass2Media LLC entered into a Contribution and Exchange Agreement with Cascade Sciences, LLC, to create a new entity “Sinclair Scientific LLC”. The existing shareholders of Mass2Media LLC and Cascade Sciences, LLC became the shareholders in the newly created entity. Consequently, Gage became an 8% holder of Cascade Sciences, LLC.

On September 29th, 2021, Agrify Corporation purchased Cascade Sciences, LLC. As part of the agreement, Gage received $1,881,781 in cash and a total of 61,387 shares, which were valued at $1,272,553. As of December 31, 2021, the shares were classified within the 'Marketable Securities' line of the statement of financial position and had a value of $565,029.

Please see below a summary of the movement in the Mass2Media LLC investment
 

 

 

December 31, 2021

 

Balance, beginning of the period

$

 

5,900,000

 

Impairment of investment

 

 

(2,829,820

)

Disposal of investment

 

 

(3,070,180

)

Balance, end of period

 

 

 

 

(b)
Cookies Creative Consulting & Promotions, LLC

On February 20, 2019, the Company, through one of its Michigan subsidiaries, entered into a convertible promissory note purchase agreement with a California Limited Liability Company (CLLC) - Cookies Creative Consulting & Promotions, LLC. The Company, through a purchase of convertible debt, invested $1 Million in exchange for a convertible promissory note with the principal amount of same bearing interest at 2.55% per annum with a two-year maturity date and the option to extend the maturity date for two years. In February 2021, the Company elected to extend the maturity date for an additional year. In February 2022, the Company elected to take the last available maturity date, moving the maturity date to February 20, 2023. Upon a liquidity event, the Company at its sole discretion, may convert the note, together with all unpaid accrued interest thereon, into Membership Units, on such terms as the Company and the Holder reasonably agree, at a conversion price equal to the Qualified Financing Cap (equal to $100 million dollars) divided by the aggregate number of outstanding shares of Common Stock immediately prior to such Maturity Date, on a Fully Diluted Basis.

This investment was fair valued using discounted cash flows at a discount rate of 10.25%, with gain (loss) in fair value for the year ended December 31, 2021 of $77,451. Below is the movement in this convertible promissory note:

 

 

 

December 31, 2021

 

Balance, beginning of the period

$

 

987,797

 

Changes in fair value

 

 

77,451

 

Balance, end of period

 

 

1,065,248

 

 

16


Gage Growth Corp.

(c)
Mesh Ventures, LLC

On February 20, 2019, the Company, through one of its Michigan subsidiaries entered into a Subscription Agreement to purchase Class A Common Units and /or Class B Common Units of a Delaware limited liability company – Mesh Ventures LLC, by making a capital investment of $1,500,000. The Company has valued our investment by assessing the valuation of specific investments within this fund, using the latest imputed valuation based on capital raises or sales multiples based on comparable companies in the industry. The Company has elected to value this investment using the cost method.

 

 

 

December 31, 2021

 

Balance, beginning of the period

$

 

421,941

 

Changes in fair value

 

 

 

Balance, end of period

 

 

421,941

 

 

(d)
Noya Cannabis Inc.

 

On November 22, 2019, the Company and Radicle Cannabis Holdings Inc. (“Radicle”) entered into a credit facility in the form of a 12% secured convertible debenture agreement in the principal amount of CAD $500,000. The maximum principal allowed under the facility is CAD $1,000,000. On June 9, 2021, the Company invested an additional CAD $500,000 into the facility, reaching the maximum under the existing facility. Subsequent to the transaction, Radicle changed its name to Noya Cannabis Inc. (“Noya”). The debenture bears interest at 12% per annum on outstanding principal and is payable semi-annually in arrears. The debenture matures on November 22, 2022, however, it can be converted into fully paid common shares at a conversion price of CAD $0.60 per common share. The convertible debenture is secured against all of Radicle’s personal property, and all of the proceeds thereof. The Company records the convertible debenture at fair value, utilizing an interest rate of 11%.

Below is the movement in this convertible debenture:

 

 

 

December 31, 2021

 

Opening Balance

$

 

379,145

 

Advances during the period

 

 

413,394

 

Changes in fair market value of convertible debentures

 

 

32,115

 

Foreign exchange gain (loss)

 

 

(17,586

)

Ending Balance

$

 

807,068

 

 

9.
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Accounts payable and accrued liabilities is comprised of:

 

 

 

December 31, 2021

 

Trade payables

$

 

24,380,360

 

Accrued liabilities

 

 

4,856,564

 

Accrued payroll

 

 

2,851,315

 

Sales tax payable

 

 

1,533,679

 

 

$

 

33,621,918

 

 

10.
LEASES

The majority of the Company’s leases are operating leases used primarily for corporate offices and retail locations. The operating lease periods generally range from 1 to 8 years.

 

Amounts recognized in the consolidated balance sheets were as follows:

 

 

 

December 31, 2021

 

Operating leases:

 

 

 

Operating lease right-of-use assets

$

 

2,316,794

 

 

 

 

 

Operating lease liability classified as current

 

 

439,784

 

Operating lease liability classified as non-current

 

 

2,037,189

 

Total operating lease liabilities

$

 

2,476,973

 

 

The Company recognized operating lease expense of $508,939 for the year ended December 31, 2021.

 

17


Gage Growth Corp.

During fiscal year 2021, the Company exercised its option to purchase its cultivation facility in Warren, Michigan, which was previously considered to be a financing lease. As a result of the repurchase, the Company recognized a $1,043,913 loss on the disposal of the financing lease.

 

Other information related to operating leases as of December 31, 2021 consisted of the following:

 

 

 

December 31, 2021

 

Weighted-average remaining lease term (years)

 

 

 

Operating leases

 

 

2.8

 

Finance leases

 

 

1.7

 

Weighted-average discount rate

 

 

 

Operating leases

 

 

12.6

%

Finance leases

 

 

15.0

%

 

Supplemental cash flow information related to leases were as follows:

 

 

 

December 31, 2021

 

Cash paid for amounts included in measurement of operating lease liabilities

$

 

387,391

 

Cash paid for amounts included in measurement of financing lease liabilities

$

 

235,136

 

 

Undiscounted lease obligations as of December 31, 2021 were as follows:

 

 

 

Operating

 

 

Financing

 

 

Total

 

2022

$

 

750,664

 

$

 

153,760

 

$

 

904,424

 

2023

 

 

798,969

 

 

 

96,460

 

 

 

895,429

 

2024

 

 

695,213

 

 

 

-

 

 

 

695,213

 

2025

 

 

533,664

 

 

 

-

 

 

 

533,664

 

2026

 

 

249,989

 

 

 

-

 

 

 

249,989

 

Thereafter

 

 

204,292

 

 

 

-

 

 

 

204,292

 

Total lease payments

$

 

3,232,791

 

$

 

250,220

 

$

 

3,483,011

 

 

11.
PROPERTY PURCHASE PAYABLE

 

 

 

December 31, 2021

 

Opening balance

$

 

 

Additions

 

 

6,990,116

 

Interest

 

 

345,504

 

Payments

 

 

(847,370

)

Ending balance

 

 

6,488,250

 

Less: current portion

 

 

(2,665,341

)

Non-current balance

$

 

3,822,909

 

 

On March 25, 2021, the Company purchased a property in Harrison, Michigan. The total stated sales price of the property (land and building) was $2,000,000, of which $650,000 was paid at closing. The remaining $1,350,000 was payable through a land contract. The stated interest rate on the land contract was 7%. The land contract is payable over five years, with monthly payments ranging from $3,500 to $5,000 during the first year of the contract, and monthly payments of $21,884 over the remaining life of the contract. At the end date of the contract (April 1, 2026), the Company will owe the remaining principal balance of $666,398.

 

On April 9, 2021, the Company purchased a property in Kalamazoo, Michigan. The total stated sales price of the property (land and building) was $294,000, of which $70,000 was paid at closing. The remaining $224,000 was payable through a land contract. There was no interest on the contract. The land contract is payable over ten months, with monthly payments ranging of $22,400.

 

On April 13 2021, the Company purchased a property in River Rouge, Michigan. The total stated sales price of the property (land and building) was $1,995,000, of which $500,000 was paid at closing. The remaining $1,495,000 was payable through a land contract. The stated interest rate on the land contract was 7%. The land contract is payable over three years, with monthly payments of $46,451.

 

On June 10, 2021, the Company purchased a property in Jackson, Michigan. The total stated sales price of the property (land and building) was $2,300,000, of which $1,300,000 was paid at closing. The remaining $1,000,000 was payable through a land contract.

18


Gage Growth Corp.

The stated interest rate on the land contract was 5%. The land contract is payable over one year, with the amount of monthly payments at the option of the Company.

 

On July 20, 2021, the Company purchased a property in Mt. Morris, Michigan. The total stated sales price of the property (land and building) was $1,687,500, of which $512,500 was paid at closing. The remaining $1,175,000 was payable through a land contract. The stated interest rate on the land contract was 5%, payable in monthly installments over two years.

 

On November 23, 2021, the Company purchased a property in Detroit, Michigan. The total stated sales price of the property (land and building) was $3,900,000 of which $1,500,000 was paid at closing. The remaining $2,400,000 was payable through a land contract. The stated interest rate on the land contract was 4%, payable in monthly installments over four years.
 

Financing through property purchase payable is generally secured by the property purchased through the financing.

 

12.
LOANS PAYABLE

 

 

 

Credit Facility

 

 

Other Loans

 

 

Total

 

Ending carrying amount at December 31, 2020

 

 

 

 

 

3,555,939

 

 

 

3,555,939

 

Loan principal net of transaction costs

 

 

53,419,895

 

 

 

4,255,408

 

 

 

57,675,303

 

Interest accretion

 

 

766,143

 

 

 

613,946

 

 

 

1,380,089

 

Principal and interest paid

 

 

(610,729

)

 

 

(1,062,700

)

 

 

(1,673,429

)

Effects of movements in foreign exchange

 

 

(90,200

)

 

 

 

 

 

(90,200

)

Ending carrying amount at December 31, 2021

 

 

53,485,109

 

 

 

7,362,593

 

 

 

60,847,702

 

Less: current portion

 

 

(53,485,109

)

 

 

(2,164,373

)

 

 

(55,649,482

)

Non-current loans payable

$

 

 

$

 

5,198,220

 

$

 

5,198,220

 

 

Credit Facility


On November 22, 2021, The Company entered into a loan financing agreement with Chicago Atlantic Admin, LLC with a face value of $55,000,000 (the “Credit Facility”). The loan bears interest of prime plus 7.00% per annum and matures on November 30, 2022. The loan was recorded at its fair value at inception and subsequently carried at amortized cost. The Company made interest payments of $610,729 during the year ended December 31, 2021.


The Company is subject to financial covenants as a result of the Credit Facility. The Company is in compliance with its debt covenants as of December 31, 2021. In the event that, in future periods, the Company’s financial results are below levels required to maintain compliance with any of its covenants, the Company will assess and undertake appropriate corrective initiatives with a view to allowing it to continue to comply with its covenants. Other than the covenants related to the Credit Facility, the Company is not subject to externally imposed capital requirements.

 

The Credit Facility includes Liens on the Company's licenses, personal property, and fixtures associated with the Company's lease agreements for properties in Grand Rapids, Lansing, Ferndale, Traverse City, Bay City, and Kalamazoo. These lease agreements were assessed and considered to be failed leasebacks as disclosed within footnote 13.

Other Loans


Stadium Ventures
 

On December 31, 2021, AEY Holdings, LLC (“AEY”), an affiliated license holder of the Company, entered into a Stock Purchase Agreement to purchase 100% of the stock in Stadium Ventures Inc. The terms of the Stock Purchase Agreement included a $4,500,000 promissory note which bears interest at 6.00% per annum and matures on December 31, 2024. The note was recorded at its fair value at inception and subsequently carried at amortized cost. The Company did not make any principal or interest payments on this loan during the year ended December 31, 2021.


Thrive


On July 15, 2020, AEY Capital, LLC (“AEY”), an affiliated license holder of the Company, entered into a Membership Interest Purchase Agreement to purchase 100% of the membership interest (the “Purchase Interest”) of Thrive Enterprises, LLC (“Thrive”). The Company found that this represented a common control transaction under ASC 805, and consequently the assets and liabilities acquired in the transaction were valued at the historical cost of the parent at the time of acquisition. The terms of the Purchase Interest was payable as follows:

19


Gage Growth Corp.

- $500,000 deposit of which $100,000 was non-refundable

- $250,000 on or before the first anniversary of closing

- $500,000 on or before the second anniversary of closing

- $1,500,000 on or before the third anniversary of closing

- $2,275,000 in a form of a secured promissory note


The payments were paid or payable by AEY Capital to Thrive. Consequently, the consideration payable was consolidated into the Company's consolidated financial statements, but the Company did not acquire any net assets as the net assets were already previously included within the consolidated financial statements. At the inception date, the Company recorded a corresponding adjustment to the Accumulated deficit to reflect the impact of the notes payable.


The note was recorded at its fair value at inception and subsequently carried at amortized cost. The Company made principal payments on this loan of $1,062,700 during the year ended December 31, 2021 and did not make any interest payments during the year.
 

Maturities of loans payable

 

Stated maturities of loans payable over the next five years are as follows:

 

Scheduled loan payable principal payments

 

 

 

2022

$

 

57,530,176

 

2023

 

 

3,527,579

 

2024

 

 

1,591,717

 

2025

 

 

 

2026

 

 

 

Total principal payments

$

 

62,649,472

 

 

13.
FINANCING LIABILITY

 

Failed sale and leaseback transactions

On June 26, 2020, the Company through its wholly owned subsidiary, Spartan Partners Properties LLC, entered into a Purchase Agreement with Strategic Koach Properties, LLC (“Koach”) whereby Koach purchased the Company’s real properties located in the City of Lansing for $1,600,000.

 

On June 26, 2020, the Company entered into a lease agreement with Koach on the Lansing property for a term of 10 years with two extension options of 10 years each. The terms of the lease agreements provide a one-time right of first refusal to purchase the property and the right to purchase the property for $2,400,000 million from the first to fourth anniversary of the transaction.

 

On August 25, 2020, the Company through its wholly owned subsidiary, Spartan Partners Properties LLC, entered into Purchase Agreements with Koach whereby Koach purchased the Company’s real properties located in Bay City, Michigan, Traverse City, Michigan and Kalamazoo, Michigan (the “Properties”) for a total of $5,050,000. On August 26th, 2020, the Company entered into lease agreements for the Bay City, Traverse City, and Kalamazoo properties for a term of 10 years with two extension options of 10 years each. The terms of the lease agreements provide a one-time right of first refusal to purchase the property and the right to purchase the property at fair market value from the second to fourth anniversary of the Transactions.

 

The Company concluded that the transactions did not meet all the criteria to qualify as a sale under ASC 606 'Revenue from Contracts with Customers' due to the substantive repurchase options on the Properties, whereby the Company continues to assume significant risks and rewards from the ownership. Accordingly, the Transaction is accounted for as a financing in accordance with and not as a sale until the repurchase options lapse and the transfer of risks and rewards associated with the ownership are transferred to Koach. The Company used the transaction price as the basis of fair value and used amortized cost method to record changes to the liabilities through the anticipated repurchase date. The liabilities incurred related to the financing are included in the Deferred financing sales and leaseback account in the consolidated balance sheets. During the year ended December 31, 2021, the Company recognized $1,221,252 of interest expense associated with the failed sale leaseback transactions.

 

Please see below for additional financial information associated with the failed sale leaseback transactions:

 

20


Gage Growth Corp.

Property and equipment associated with sale and leaseback transactions

 

11,482,784

 

Discounted Payments owed - through repurchase date

 

2,136,924

 

Undiscounted Payments owed - through repurchase date

 

5,165,978

 

Repurchase amount

 

20,805,000

 

 

 

14.
DEBENTURE PAYABLE

 

On September 30, 2020, the Company issued the following debentures:

 

a) 2,300 units of CAD 1,000 per unit ("CAD Unit"). Each CAD Unit was comprised of one (1) CAD 1,000 debenture and 67 share purchase warrants. Each warrant entitles the holder to purchase one Subordinate Voting Share at a price of CAD 1.50 for a period of 18 months following a liquidity event as defined under the warrant certificate.

 

b) 750 units at USD 1,000 per unit ("USD Unit"). Each USD Unit was comprised of one (1) USD 1,000 debenture and 87 share purchase warrants. Each warrant entitles the holder to purchase one Subordinate Voting Share at a price of USD 1.15 for a period of 18 months following a liquidity event as defined under the warrant certificate.

 

The debentures are unsecured and carry a coupon rate of 12.5% with a term of 12 months. The CAD debentures were valued using a market interest rate of 15%, with the remaining value assigned to the share purchase warrants. The USD share purchase warrants were valued using an expected life of 2 years and an annualized volatility of 81.4%, and a share price valuation of 1.50 CAD with the remaining value assigned to the debenture.

 

On April 6, 2021, a liquidity event occurred when the Company became publicly listed on the Canadian Securities Exchange ("CSE"). This triggered the start of the exercise period for both the USD and CAD warrants as described above.

 

On September 28, 2021, the Company amended the previously issued debentures to extend the maturity date from September 30, 2021 to January 28, 2022. As part of the amendment, the Company is permitted to redeem all of or a part of the debentures outstanding with no penalty. In total, the Company elected to early exercise 200 CAD units as of December 31, 2021. These debentures were paid out by the Company during the year. The amendment did not represent a substantial modification of the debentures.

 

Please see below for a summary of movement in the debenture during the period:

 

 

 

$

 

Balance, December 31, 2020

 

 

2,593,197

 

Repayment

 

 

(289,126

)

Interest

 

 

494,479

 

Fair value change of liability-classified warrants

 

 

28,126

 

Impact of foreign currency

 

 

47,551

 

(Gain)/loss on modification

 

 

(70,197

)

Balance, December 31, 2021

 

 

2,804,030

 

 

The debenture balance was fully paid in January 2022, as stipulated by the amended debenture agreement.

15.
SHAREHOLDERS EQUITY

 

The authorized share capital of the Company is comprised of the following:

 

Unlimited number of Subordinate Voting Shares

Holders of the Subordinate Voting Shares are entitled to notice of and to attend any meeting of the shareholders of the Company, except a meeting of which only holders of another particular class or series of shares of the Company shall have the right to vote.

 

Voting Rights

At each such meeting holders of Subordinate Voting Shares shall be entitled to one vote in respect of each Subordinate Voting Share held.

 

Dividends

The holders of Subordinate Voting Shares are entitled to receive as and when declared by the directors, dividends in cash or property of the Company. No dividend will be declared or paid on the Subordinate Voting Shares unless the Company simultaneously declares or

21


Gage Growth Corp.

pays, as applicable, equivalent dividends (on an as-converted to Subordinate Voting Share basis) on the Multiple Voting Shares and Super Voting Shares.

 

Unlimited number of Super Voting Shares

Holders of Super Voting Shares are entitled to notice of and to attend at any meeting of the shareholders of the Company, except a meeting of which only holders of another particular class or series of shares of the Company shall have the right to vote.

 

Voting Rights

At each such meeting, holders of Super Voting Shares are entitled to 50 votes in respect of each Subordinate Voting Share into which such Super Voting Share could ultimately then be converted.

 

Dividends

Holders of Super Voting Shares do not have the right to receive dividends.

 

Exchangeable Units

The Company has 1,500,000 Exchangeable Units issued by Spartan Partners Holding, LLC as of December 31, 2021. The Exchangeable Units are exchangeable for either 75,000,000 Subordinate Voting Shares or 1,500,000 Proportionate Voting Shares of the Company. As Exchangeable Units are converted to Subordinate Voting Shares by the holder, the related Super Voting Shares are retired. There were no exchanges during the years ended December 31, 2021.

 

Warrants

The following is a summary of the outstanding warrants for Common Shares:

 

 

 

Number of Common Share Warrants Outstanding

 

 

Number of Common Share Warrants Exercisable

 

 

Weighted Average Exercise Price $

 

 

Weighted Average Remaining Life (years)

 

Outstanding, December 31, 2020

 

 

32,820,495

 

 

 

32,820,495

 

 

$

2.25

 

 

 

2.70

 

Granted

 

 

780,727

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(60,300

)

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2021

 

 

33,540,922

 

 

 

33,150,559

 

 

$

2.25

 

 

 

1.73

 

 

On December 14, 2020, December 30, 2020, and January 27, 2021, the Company closed its offering (the “Reg A Offering”) of Subordinate Voting Shares pursuant to Regulation A, Tier 2, of the U.S. Securities Act. As part of this offering, the Company issued a total of 28,571,400 Subordinate Voting Shares. The offering was at $1.75 USD per share. As part of the offering, the Company also issued 23,757,145 warrants to its largest subscriber. All warrants were issued during December of 2020. These warrants allowed the subscriber to purchase shares at $2.60 USD at any point within three years of the issue date. The Company split the equity raised between the warrant liability and additional paid in capital. The Company also reduced share capital by $1,001,032 associated with transaction costs directly attributable to the offering.

 

On July 1, 2021, Spartan Partners Licensing (“SPL”) signed an agreement with KKE Licensing, MI LLC (“KKE”). The IP agreement allows SPL and its affiliates the exclusive right to utilize the license and branding of KKE within the state of Michigan. The initial term of the agreement is 5 years from the commencement date, where the commencement date is the earlier of the first day of the month after the first shipment of products under the deal or November 1st. As part of the agreement, SPL pays a royalty fee of 5% on products sold under the agreement. In addition, SPL granted warrants as part of the agreement. The warrants were issued in order to maintain the Company’s exclusive right to utilize KKE’s name and branding within the State of Michigan. In total, 780,727 warrants were determinable and granted as part of the agreement, with 390,364 vesting on July 2nd, 2021, and 390,363 vesting on July 2nd, 2022. In addition, $500,000 worth of warrants will be granted on July 2, 2023 and $500,000 worth of warrants will be granted on July 2, 2024. The number of warrants to be issued in 2023 and 2024 will be determined on the date of issuance based on the prevailing share price and volatility.

 

The Company determined that the exclusive right to KKE’s name and branding represented an Intangible asset, and capitalized $2,018,185 million related to this Intangible asset, with the amount determined based on the value of warrants granted. The warrants granted as part of this agreement are included within the Warrant liability on the balance sheet.

 

 

16.
SHARE-BASED PAYMENTS AND SHARE-BASED COMPENSATION EXPENSE

22


Gage Growth Corp.

 

Share-based payments

 

The Company recorded $3,306,193 of expense associated with share-based payments during the fiscal year ended December 31, 2021.

 

On July 20, 2021, the Company issued 175,000 shares in exchange for prior services and real estate purchases at a fair value of $1.87 per share for a fair value of $327,250.

 

On April 6, 2021, the Company issued 1,000,000 shares to the CEO at a fair value of $1.75 per share for a fair value of $1,750,000.On March 9, 2021, the Company issued 425,000 Subordinate Voting Shares to contractors of the Company at a fair value of USD $1.75 per share for a value of $743,750. The shares vested immediately upon issuance and the Company recorded a share-based expense of $743,750.

 

On February 19, 2021, the Company issued 100,000 Subordinate Voting Shares at a fair value of USD$1.75 per share for a value of $175,000. The shares vested immediately upon issuance and the Company recorded a share-based expense of $175,000.

 

Stock Option plan:

 

The Company has adopted an incentive stock option plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, grant to directors, officers, employees, and consultants of the Company non-transferable options to purchase common shares, provided that the number of Subordinate Voting Shares reserved for issuance under the Stock Option Plan shall not exceed fifteen percent (15%) of the issued and outstanding Subordinate Voting Shares. The options are exercisable for a period of up to five years.

 

The Board of Directors determines the price per Subordinate Voting share and the number of Subordinate Voting Shares that may be allocated to each director, officer, employee, and consultant and all other terms and conditions of the option. The following table summarizes the stock option activity for the years ended December 31, 2021:

 

 

 

Number of Stock Options

 

Weighted average remaining contractual life (in years)

 

Weighted Average Exercise Price (per share) $

 

Aggregate intrinsic value

 

Weighted average fair value of nonvested options (per share) $

Outstanding, December 31, 2020

 

               13,621,827

 

                          3.24

 

$0.72

 

N/A

 

                          0.56

Granted

 

                 2,731,400

 

 

 

                          1.75

 

 

 

 

Exercised

 

                   (434,164)

 

 

 

                          1.18

 

 

 

 

Forfeited

 

                   (210,527)

 

 

 

                          1.52

 

 

 

 

Outstanding, December 31, 2021

 

               15,708,536

 

                          2.53

 

$0.87

 

               14,463,726

 

                          0.87

 

 

 

 

 

 

 

 

 

 

 

Exercisable, December 31, 2021

 

                 9,334,873

 

                          2.02

 

$0.58

 

               11,284,179

 

N/A

 

 

 

 

 

 

 

 

 

 

 

Nonvested, December 31, 2021

 

                 6,373,663

 

                          3.29

 

$1.09

 

                 3,179,547

 

N/A

 

The fair value of stock options granted is amortized over the vesting period of which $3,496,477 has been expensed and recorded as Additional paid in Capital during fiscal year ended December 31, 2021.

 

The intrinsic value of the options exercised during the years ended December 31, 2021 was $307,418. The total compensation cost related to non-vested option awards not yet recorded at December 31, 2021 was $1,900,289 which is expected to be recognized over a weighted-average of 1.27 years.

 

In determining the amount of share-based compensation related to options issued during the for the year ended December 31, 2021, the Company used the Black-Scholes pricing model to establish the fair value of the options granted with the following assumptions

 

23


Gage Growth Corp.

 

 

December 31, 2021

Volatility

 

86%-108%

Risk-free interest rate

 

0.25%-0.74%

Expected life (years)

 

5

Dividend yield

 

0%

Forfeiture rate

 

10%-15%

 

 

 

 

 

17.
NON-CONTROLLING INTEREST

 

Non-controlling interest (“NCI”) represents equity interests in consolidated entities that are owned by parties that are not shareholders of the ultimate parent. Non-controlling interest is to be initially measured either at fair value or at the non-controlling interest’s proportionate share of the recognized amounts of the acquiree’s identifiable net assets. The choice of measurement is made on a transaction-by-transaction basis. The share of net assets attributable to non-controlling interests is presented as a component of equity. Their share of net income or loss is recognized directly in equity. Changes in the parent company’s ownership interest that do not result in a loss of control are accounted for as equity transactions.

 

Effective February 11, 2021, Spartan Services terminated its services agreement, its license agreement and its membership interest transfer restriction and succession agreement with Buena Vista.

 

As of December 31, 2021, non-controlling interest included the following amounts before intercompany eliminations:

 

 

Cookies Retail Canada

Spartan Services LLC

Spartan Licensing LLC

Spartan Properties LLC

Spartan Holdings LLC

AEY Capital LLC

Thrive Enterprises

3 State Park LLC

Buena Vista Real Estate

AEY Holdings, LLC

Total

Total Assets

          1,312,770

        52,103,129

          5,302,025

        47,778,654

                    -

        23,977,054

          4,936,507

                    -

                    -

        10,312,651

      145,722,790

Total Liabilities

        (1,686,031)

      (55,820,097)

        (2,096,826)

      (46,569,091)

                    -

      (60,552,874)

      (14,445,204)

        (1,246,721)

           (437,137)

      (16,147,420)

    (199,001,401)

Net Assets

           (373,261)

        (3,716,968)

          3,205,199

          1,209,563

                    -

      (36,575,820)

        (9,508,697)

        (1,246,721)

           (437,137)

        (5,834,769)

      (53,278,611)

Net Assets attributable to NCI

             (74,652)

        (1,810,164)

          1,563,727

             589,058

                    -

      (36,575,820)

        (9,508,697)

        (1,246,721)

           (437,137)

        (5,834,769)

      (53,335,175)

 

 

 

 

 

 

 

 

 

 

 

 

For year ended December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

Revenue

                    -

        47,485,917

          2,980,000

          2,330,080

                    -

        95,884,728

        20,412,428

                    -

                    -

          7,292,353

      176,385,506

Net Income (loss)

           (273,695)

           (240,755)

             540,597

        (3,329,347)

                    -

      (16,498,458)

        (3,953,209)

           (399,914)

             (44,661)

        (3,322,021)

      (27,521,463)

Net Income (loss) attributable to NCI

             (54,738)

           (117,247)

             263,271

        (1,621,392)

                    -

      (16,498,458)

        (3,953,209)

           (399,914)

             (44,661)

        (3,322,021)

      (25,748,369)

 

 

 

 

 

 

 

 

 

 

 

 

NCI percentage at December 31, 2021

20.00%

48.70%

48.70%

48.70%

48.70%

100.00%

100.00%

100.00%

100.00%

100.00%

 

 

18.
REVENUE

 

Revenues are primarily generated from sales of cannabis products sold to customers through provision centers. In addition, the Company generates a portion of revenue through wholesale sales of flower, distillate, and trim.

 

 

 

December 31, 2021

 

Wholesale

$

 

12,805,730

 

Retail

 

 

78,694,037

 

Total

$

 

91,499,767

 

 

For the year ended December 31, 2021, the Company did not have any single customer that accounted for 10% or more of the Company's revenue.

19.
GENERAL AND ADMINISTRATIVE EXPENSES

 

The Company’s general and administrative expenses were as follows:

24


Gage Growth Corp.

 

 

 

For the year ended

 

 

 

December 31, 2021

 

Salaries and benefits

$

 

20,211,065

 

Office and administrative

 

 

7,627,436

 

Professional fees

 

 

6,960,162

 

Share-based payments

 

 

6,494,788

 

Consulting fees

 

 

3,219,969

 

Licenses

 

 

1,626,928

 

Insurance

 

 

1,509,720

 

Repair and maintenance

 

 

590,488

 

Travel and entertainment

 

 

480,265

 

Property taxes

 

 

303,725

 

Total

$

 

49,024,546

 

 

20.
SALES AND MARKETING EXPENSES

The Company’s sales and marketing expenses were as follows:

 

 

For the year ended

 

 

 

December 31, 2021

 

Marketing service

$

 

2,501,844

 

Royalty and commission

 

 

2,414,824

 

Advertising and promotion

 

 

2,120,656

 

Public relations

 

 

47,038

 

Sponsorship

 

 

5,025

 

Total

$

 

7,089,387

 

 

21.
CAPITAL MANAGEMENT

The Company's objective in managing capital is to ensure a sufficient liquidity position to safeguard the Company's ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders.

Since inception, the Company has primarily financed its liquidity needs through the issuance of share capital, property purchase payables, and debt. The equity issuances are outlined in footnote 15, the property purchases payable are outlined in footnote 11, the debenture payable is outlined in footnote 14, and the debt is outlined in footnote 12.

The Company is subject to financial covenants as a result of its loans payable with various lenders. The Company is in compliance with its debt covenants as of December 31, 2021. In the event that, in future periods, the Company's financial results are below levels required to maintain compliance with any of its covenants, the Company will assess and undertake appropriate corrective initiatives with a view to allowing it to continue to comply with its covenants. Other than these items related to loans payable, the Company is not subject to externally imposed capital requirements.

22.
FAIR VALUE MEASUREMENT AND RISK MANAGEMENT

 

Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Fair value measurements are based on a framework that utilizes the inputs market participants use to determine the fair value of an asset or liability and establishes a fair value hierarchy to prioritize those inputs. The fair value hierarchy is comprised of the three levels described below:

 

Level 1 – Inputs based on quoted prices in active markets for identical assets or liabilities.

Level 2 – Inputs other than Level 1 quoted prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level 3 – Unobservable inputs based on little or no market activity and that are significant to the fair value of the assets and liabilities.

 

The fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions regarding what a third party would use in pricing an asset or liability based on the best information available under the circumstances. A financial instrument’s categorization within the fair value hierarchy is based upon the

25


Gage Growth Corp.

lowest level of input that is significant to the fair value measurement. Cash and cash equivalents, net accounts receivable, accounts payable and accrued liabilities, loans payable, investments, and prepaid and other current assets represent financial instruments for which the carrying amount approximates fair value due to their short-term maturities.

 

Assets and liabilities measured at fair value at December 31, 2021, were as follows:

 

Recurring fair value measurements

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total fair value

 

Recurring fair value measurements

$

 

 

$

 

 

$

 

 

$

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

45,455,583

 

 

 

 

 

 

 

 

 

45,455,583

 

Marketable securities

 

 

84,197

 

 

 

 

 

 

 

 

 

84,197

 

Investments

 

 

 

 

 

1,872,316

 

 

 

 

 

 

1,872,316

 

Total assets recurring fair value measurements

 

 

45,539,780

 

 

 

1,872,316

 

 

 

 

 

 

47,412,096

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

 

 

 

 

21,734,596

 

 

 

 

 

 

21,734,596

 

Total liabilities recurring fair value measurements

$

 

 

$

 

21,734,596

 

$

 

 

$

 

21,734,596

 

 

The Company determines the fair value of its financial assets and liabilities using the following methodologies:

 

Marketable securities – These instruments include equity securities with readily determinable fair values. The fair value is obtained based on observable market prices quoted on public exchanges for the instruments.

 

Investments – Certain convertible debenture securities are included in the investments section of the balance sheet. These investments are fair valued using the discounted cash flows based on actively quoted interest rates that are readily accessible and observable. For the year ended December 31, 2021, these investments were valued using a discount rate of 11%.

 

Warrant liabilities – These instruments include liability-classified warrant instruments. The warrant liability was valued using the Black Scholes simulation valuation model. Key inputs used in the Black Scholes simulation valuation model used were as follows:

 

 

 

December 31, 2021

 

Common Stock Price of Gage Growth

 

 

1.79

 

Warrant Exercise Price

 

 

2.60

 

Annual volatility

 

 

85.8

%

Annual risk-free rate

 

 

0.73

%

Expected term

 

2 years

 

 

There were no transfers between the levels of fair value hierarchy during the year ended December 31, 2021.

 

Risk management

 

The Company's risk exposure and the impact on the Company's financial instruments are summarized below:

a) Credit risk

 

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, accounts receivable, and investments. The Company assesses the credit risk of trade receivables by evaluating the likelihood of repayment on a customer-level basis. The carrying amounts of trade receivables are reduced through the use of an allowance account and the amount of the loss is recognized in the consolidated statements of operations and comprehensive loss. When a trade receivable balance is considered uncollectible, it is written off against the allowance for expected credit losses.

 

The Company has reviewed the items comprising the accounts receivable balance and determined that the majority of accounts are collectible. An allowance for doubtful accounts has been recorded. Subsequent recoveries of amounts previously written off are credited against general administration expenses in the consolidated statements of operations. The Company regularly monitors credit risk exposure and takes steps to mitigate the likelihood of these exposures resulting in an actual loss. As of December 31, 2021, 85% of the Company's outstanding receivables were owed from PureX, LLC, a wholesale customer of the Company.

 

b) Liquidity risk

 

26


Gage Growth Corp.

The Company is exposed to liquidity risk, or the risk that the Company will not be able to meet its financial obligations as they become due. The Company manages liquidity risk through ongoing review of its capital requirements. The Company's objective with respect to its capital management is to ensure it has sufficient cash resources to maintain its ongoing operations.

 

c) Market risk

 

The significant market risk exposures to which the Company is exposed are foreign currency risk and interest rate risk

i) Foreign currency risk:

 

Foreign currency risk is the risk that a variation in exchange rates between the Canadian dollar and the US dollar and other foreign currencies will affect the Company's operations and financial results.

 

The Company and its subsidiaries hold loans payable in currencies other than their functional currency. The Company does not currently engage in currency hedging activities to limit the risks of currency fluctuations. Consequently, fluctuations in foreign currencies could have a negative impact on the profitability of the Company's operations. A 10% increase in the value of the US dollar compared to the Canadian dollar would result in a $4.9 million gain. A 10% decrease in the value of the US dollar compared to the Canadian dollar would result in a $5.9 million loss.

 

ii) Interest rate risk:

 

Interest rate risk is the risk that future cash flows will fluctuate as a result of changes in market interest rates. The Company is exposed to variable interest rate through its Credit Facility. The loan bears interest of prime plus 7% per annum and matures on November 30, 2022. An increase in the prime rate of 1% would result in the Company paying $469,410 more over the term of the loan, which is fully payable during 2022. A decrease in the prime rate of 1% would result in the Company paying $667,257 less over the term of the loan.

 

The Company does not have significant cash equivalents at year end. The Company's loans payable, other than the Credit Facility discussed above, have fixed interest rates from 0%-6%.

 

23.
INCOME TAXES

 

The domestic and foreign components of loss before income taxes for the year ended December 31, 2021 are as follows:

 

 

 

December 31, 2021

 

Canada

$

 

(15,496,084

)

United States

 

 

(19,994,489

)

Loss before income taxes

$

 

(35,490,573

)

 

The provision for income taxes expense for the year ended December 31, 2021 consists of:

 

 

 

December 31, 2021

 

Current:

 

 

 

Federal

$

 

9,955,469

 

State

 

 

-

 

Total current

$

 

9,955,469

 

 

 

 

 

Deferred:

 

 

 

Federal

$

 

(871,988

)

State

 

 

(245,100

)

Total deferred

 

 

(1,117,088

)

 

 

 

 

Total income tax provision (benefit)

$

 

8,838,381

 

 

As the operations of the Company are predominantly US based, the Company has prepared the reconciliation of expected income tax to the actual income tax provision using the US Federal tax rate of 21% for the year ended December 31, 2021. The reconciliation is as follows:

 

27


Gage Growth Corp.

 

 

December 31, 2021

 

Net loss before tax for the year

$

 

(35,490,574

)

Expected income tax (recovery) expense

 

 

(7,453,021

)

Tax rate changes and other adjustments

 

 

(2,592,680

)

Expenses not deductible under IRC 280E

 

 

12,740,405

 

Stock based compensation and other

 

 

412,246

 

Change in tax benefits not recognized

 

 

5,731,431

 

(Recovery) Expense

$

 

8,838,381

 

 

 

As the Company operates in the cannabis industry, the Company is subject to the limits of IRC Section 280E under which the Company is only allowed to deduct expenses directly related to the cost of producing the products or cost of production. This results in permanent differences between ordinary and necessary business expenses deemed unallowable under IRC Section 280E.

 

Provisions for taxes are reviewed at the end of each period using the best estimate of the amount to be paid based on a qualitative assessment of all relevant factors. It is possible that at some future date an additional liability could result from audits by taxing authorities. Where the final outcome of these tax related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made.

The following table summarize the components of deferred tax:

 

 

 

December 31, 2021

 

Deferred tax assets

 

 

 

Operating tax losses carried forward

$

 

5,726,597

 

Capital lease obligations

 

 

3,126,002

 

Unrealized foreign exchange

 

 

519,344

 

Deferred revenue

 

 

153,243

 

Investments

 

 

842,040

 

Inventory reserve

 

 

359,119

 

Allowance for doubtful accounts

 

 

201,000

 

Other

 

 

293,963

 

Total deferred tax assets

 

 

11,221,308

 

Valuation allowance

 

 

(8,493,439

)

Net deferred tax assets

$

 

2,727,869

 

 

 

 

 

Deferred tax liabilities

 

 

 

Property, plant and equipment

 

 

(56,479

)

Right of use assets

 

 

(2,557,228

)

Investments

 

 

-

 

Other

 

 

(114,162

)

Total deferred tax liabilities

 

 

(2,727,869

)

 

 

 

 

Net deferred tax liabilities

$

 

-

 

 

As of December 31, 2021, the Company has $11,941,250 of Canadian net operating loss carryovers that expire at different times, the earliest of which is 2038 for $201,620. As of December 31, 2021, the Company has $299,533 of domestic federal net operating loss carryovers with no expiration date and has $36,520,718 of state net operating loss carryovers with no expiration date. The statute of limitations with respect to our federal returns remains open for tax years 2019 and forward.

 

As the Company operates in the cannabis industry, it is subject to the limitations of IRC Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-deductible under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income or loss.

24.
SEGMENT INFORMATION

 

For the year ended December 31, 2021, the Company operates in one segment, which is the production and sale of medical and adult-use cannabis. The Company operates with subsidiaries located in Canada and the US. Operational subsidiaries in Canada were not significant to the business.

28


Gage Growth Corp.

25.
RELATED PARTY TRANSACTIONS

 

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control. Related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

 

The Corporation’s key management personnel have authority and responsibility for overseeing, planning, directing and controlling the activities of the Corporation. Key management personnel include members of the Board of Directors, Chief Executive Officer/President and Chief Financial Officer. Compensation of key management personnel may include short-term and long-term benefits. Short-term benefits include salaries and bonuses. Share-based compensation include warrants and stock options vested during the year.

 

As part of the Reg. A offering as described in footnote 14, the Company issued 23,757,145 shares and 23,757,145 warrants to entities controlled by Jason Wild, which gave Jason Wild over 10% ownership in the Company.

 

26.
COMMITMENTS AND CONTINGENCIES

 

Legal proceedings

 

In the normal course of business, the Company may become involved in legal disputes regarding various litigation matters. In the opinion of management, any potential liabilities resulting from such claims would not have a material effect on the financial statements.

 

The Company is engaged in a legal proceeding surrounding the property for a provisioning center located in Detroit, MI. In 2019, the Company agreed to purchase the property from the owner and began to operate in the property on an informal lease. The parties disagreed surrounding agreed-upon compensation related to the purchase agreement. Based on our understanding of a likely settlement amount relating to the legal dispute, the Company recorded a legal reserve and corresponding expense of $1,500,000 million, which represents a total settlement of $5,000,000 million less the approximate fair value of the property of $3,500,000 million.

 

The Company had previously signed an agreement to purchase a building for a retail facility. The Company does not intend to finalize the purchase of the property and has been engaged in negotiations with the counterparty. The Company recorded a legal reserve and corresponding expense of $1,200,000 million, which represents the most likely amount of the future settlement obligation.

 

Contractual Construction Agreements

 

The Company has entered into construction contracts with six contractors for four locations under construction as of December 31, 2021. The sum of these contracts as of December 31, 2021 was $16,261,645, the sum owing totaled $618,803, and pre-payments to contractors for work not yet completed was $1,310,860.

27.
SUBSEQUENT EVENTS

 

On March 10, 2022, the Company was purchased by TerrAscend Corp. ("TerrAscend"). As part of the transaction, Gage shareholders received 51,349,978 TerrAscend common shares, 13,504,500 exchangeable units, 5,221,542 replacement stock options, and 282,023 replacement warrants.

 

On May 19, 2022, the Company came to an agreement with the counterparty surrounding the litigation for the provisioning center located in Detroit, MI, as disclosed in footnote 26. The Company settled for a total of $5,000,000, with $3,500,000 being allocated to the underlying property. The remaining $1,500,000 was recorded as a litigation expense during 2021 and was accrued in as Accounts payable and accrued liabilities as of December 31, 2021. The amount was paid on May 20, 2022.

 

 

 

 

29



EX-99.2

Exhibit 99.2

 

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION OF TERRASCEND AND GAGE

 

On March 10, 2022, TerrAscend Corp. ("TerrAscend" or the "Company") acquired all of the issued and outstanding subordinate voting shares (or equivalent) of Gage Growth Corp. ("Gage"), a cultivator and processor with operations in the Michigan market. Pursuant to the terms of the arrangement agreement (the "Arrangement"), for each Gage subordinate voting share and other equity instruments, including outstanding stock options and warrants, each holder received a 0.3001 equivalent replacement award of the Company's respective security at the time of closing based on the closing price of the Common Shares on the Canadian Stock Exchange ("CSE") on March 10, 2022. On the acquisition date, there was consideration in the form of 51,349,978 Common Shares, 13,504,500 exchangeable units, 5,221,542 replacement stock options, 282,023 replacement warrants, and 7,129,519 liability classified warrants convertible into equity. Each of the directors, officers, and 10% shareholders of Gage entered into voting support and lock-up agreement in which the shares issued to these individuals are subject to various vesting periods. As such, a restriction discount of $45,336 has been placed over the shares subject to lock-up. Total consideration was valued at $294,800.

 

The following unaudited pro forma condensed combined financial statements (the "pro forma financial statements") are presented to illustrate the estimated effects of the acquisition of Gage (the "Gage Acquisition"), which has been accounted for as a business combination. The pro forma financial statements have been prepared in accordance with Article 11 of Regulation S-X.

 

The historical financial information of the Company has been derived from the audited consolidated financial statements of the Company as of December 31, 2021, as found in Form 10-K which was filed with the Securities and Exchange Commission ("SEC") on March 17, 2022. The historical financial information of Gage has been derived from the audited financial statements of Gage for the year ended December 31, 2021, included in Exhibit 99.1 to the Company's Form 8-K/A filed with the SEC on May 24, 2022.

 

The following unaudited pro forma combined condensed balance sheets (the "pro forma balance sheet") as of December 31, 2021 is presented as if the Gage Acquisition had occurred as of December 31, 2021. The unaudited pro forma combined condensed statements of operations (the "pro forma statements of operations") for the year ended December 31, 2021 are presented as if the Gage Acquisition occurred on January 1, 2021.

 

The pro forma adjustments are based on preliminary estimates and currently available information and assumptions that the Company believes are reasonable. Included in the pro forma condensed combined financial information is an estimate of the consideration exchanged for Gage which is based on known information and preliminary estimates of fair value for certain equity instruments. While this is the Company's best estimates at this time, the valuation of these amounts is still in progress and subject to change. All estimates and assumptions included in these pro forma statements could change significantly as the Company finalizes its assessment of the allocation and fair value of the net assets acquired. The unaudited combined financial information does not include adjustments to reflect any synergies or dis-synergies, any future operating efficiencies, associated costs savings, or any possible integration costs that may occur related to the Gage Acquisition. Actual results may be materially different than the pro forma information presented herein.

 

The pro forma financial statements do not necessarily reflect what the combined company's financial condition or results of operations would have been had the Gage Acquisition occurred on the dates indicated. They also may not be useful in predicting the future financial condition and results of operations of the combined company. The actual financial condition and results of operations of the combined company may differ significantly from the pro forma amounts reflected herein due to a variety of factors, including differences in accounting policies, elections, and estimates, which while accounted for to the extent known, are still in process of being determined.

 


TerrAscend Corp.

Unaudited Pro Forma Condensed Combined Balance Sheet as of December 31, 2021

(Amounts expressed in thousands of United States dollars, except for per share amounts)

 

 

 

TerrAscend

 

 

Gage

 

 

Adjustments

 

 

Notes

 

Pro Forma Combined

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

79,642

 

 

$

42,901

 

 

$

-

 

 

 

 

$

122,543

 

Restricted cash

 

 

 

 

 

1,800

 

 

 

 

 

 

 

 

1,800

 

Accounts receivable, net

 

 

14,920

 

 

 

7,700

 

 

 

 

 

 

 

 

22,620

 

Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory

 

 

42,323

 

 

 

17,639

 

 

 

5,579

 

 

(a)

 

 

65,541

 

Prepaid Expenses and other current assets

 

 

6,336

 

 

 

2,699

 

 

 

 

 

 

 

 

9,035

 

 

 

 

143,221

 

 

 

72,739

 

 

 

5,579

 

 

 

 

 

221,539

 

Non-Current Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

140,762

 

 

 

68,473

 

 

 

1,362

 

 

(b)

 

 

210,597

 

Deposits

 

 

 

 

 

1,541

 

 

 

 

 

 

 

 

1,541

 

Operating lease right of use assets

 

 

29,561

 

 

 

2,317

 

 

 

 

 

 

 

 

31,878

 

Intangible assets, net

 

 

168,984

 

 

 

8,814

 

 

 

179,475

 

 

(c)

 

 

357,273

 

Goodwill

 

 

90,326

 

 

 

-

 

 

 

201,256

 

 

(d)

 

 

291,582

 

Investments

 

 

 

 

 

2,294

 

 

 

 

 

 

 

 

2,294

 

Indemnification asset

 

 

3,969

 

 

 

 

 

 

 

 

 

 

 

3,969

 

Other non-current assets

 

 

5,111

 

 

 

 

 

 

 

 

 

 

 

5,111

 

 

 

 

438,713

 

 

 

83,439

 

 

 

382,093

 

 

 

 

 

904,245

 

Total Assets

 

$

581,934

 

 

$

156,178

 

 

$

387,672

 

 

 

 

$

1,125,784

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Shareholders' Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

30,340

 

 

$

33,623

 

 

 

 

 

 

 

 

63,963

 

Deferred revenue

 

 

1,071

 

 

 

583

 

 

 

 

 

 

 

 

1,654

 

Loans payable, current

 

 

8,837

 

 

 

55,649

 

 

 

 

 

 

 

 

64,486

 

Contingent consideration payable, current

 

 

9,982

 

 

 

-

 

 

 

 

 

 

 

 

9,982

 

Lease liability, current

 

 

1,193

 

 

 

440

 

 

 

 

 

 

 

 

1,633

 

Corporate income tax payable

 

 

18,939

 

 

 

4,419

 

 

 

 

 

 

 

 

23,358

 

Other current liabilities

 

 

 

 

 

6,265

 

 

 

 

 

 

 

 

6,265

 

 

 

 

70,362

 

 

 

100,979

 

 

 

 

 

 

 

 

171,341

 

Non-Current Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loans payable, non-current

 

 

176,306

 

 

 

5,198

 

 

 

 

 

 

 

 

181,504

 

Contingent consideration payable, non-current

 

 

2,553

 

 

 

 

 

 

 

 

 

 

 

2,553

 

Lease liability, non-current

 

 

30,754

 

 

 

2,037

 

 

 

 

 

 

 

 

32,791

 

Warrant liability

 

 

54,986

 

 

 

17,230

 

 

 

(5,845

)

 

(e)

 

 

66,371

 

Deferred income tax liability

 

 

14,269

 

 

 

 

 

 

50,333

 

 

(f)

 

 

64,602

 

Financing obligations

 

 

 

 

 

12,235

 

 

 

 

 

 

 

 

12,235

 

Other long term liabilities

 

 

3,750

 

 

 

3,961

 

 

 

 

 

 

 

 

7,711

 

 

 

 

282,618

 

 

 

40,661

 

 

 

44,488

 

 

 

 

 

367,767

 

Total Liabilities

 

 

352,980

 

 

 

141,640

 

 

 

44,488

 

 

 

 

 

539,108

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share Capital

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A, convertible preferred stock, no par value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series B, convertible preferred stock, no par value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series C, convertible preferred stock, no par value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series D, convertible preferred stock, no par value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proportionate voting shares, no par value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exchangeable shares, no par value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock, no par value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional paid in capital

 

 

535,418

 

 

 

171,197

 

 

 

186,525

 

 

(f)(g)

 

 

893,140

 

Accumulated other comprehensive income (loss)

 

 

2,823

 

 

 

2,807

 

 

 

(2,807

)

 

(g)

 

 

2,823

 

Accumulated deficit

 

 

(314,654

)

 

 

(93,685

)

 

 

93,685

 

 

(g)

 

 

(314,654

)

Non-controlling interest

 

 

5,367

 

 

 

(65,781

)

 

 

65,781

 

 

(g)

 

 

5,367

 

Total Shareholders' Equity

 

 

228,954

 

 

 

14,538

 

 

 

343,184

 

 

 

 

 

586,676

 

Total Liabilities and Shareholders' Equity

 

$

581,934

 

 

$

156,178

 

 

$

387,672

 

 

 

 

$

1,125,784

 

 


TerrAscend Corp.

Unaudited Pro Forma Condensed Combined Statement of Operations and Comprehensive Income (Loss) for the year ended December 31, 2021

(Amounts expressed in thousands of United States dollars, except for per share amounts)

 

 

 

TerrAscend

 

 

Gage

 

 

Adjustments

 

 

Notes

 

Pro Forma Combined

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

222,067

 

 

$

91,500

 

 

$

-

 

 

 

 

$

313,567

 

Excise and cultivation tax

 

 

(11,648

)

 

 

 

 

 

 

 

 

 

 

(11,648

)

Revenue, net

 

 

210,419

 

 

 

91,500

 

 

 

 

 

 

 

 

301,919

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Sales

 

 

98,315

 

 

 

62,101

 

 

 

5,579

 

 

(a)

 

 

165,995

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

112,104

 

 

 

29,399

 

 

 

(5,579

)

 

 

 

 

135,924

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

80,973

 

 

 

59,323

 

 

 

 

 

 

 

 

140,296

 

Amortization and depreciation

 

 

7,656

 

 

 

1,683

 

 

 

8,879

 

 

(b)(c)

 

 

18,218

 

Total operating expenses

 

 

88,629

 

 

 

61,006

 

 

 

8,879

 

 

 

 

 

158,514

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

 

23,475

 

 

 

(31,607

)

 

 

(14,458

)

 

 

 

 

(22,590

)

Other expense (income)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revaluation of contingent consideration

 

 

3,584

 

 

 

 

 

 

 

 

 

 

 

3,584

 

(Gain) loss on fair value of warrants and purchase option derivative asset

 

 

(57,904

)

 

 

(6,231

)

 

 

 

 

 

 

 

(64,135

)

Finance and other expenses

 

 

29,229

 

 

 

3,977

 

 

 

 

 

 

 

 

33,206

 

Transaction and restructuring costs

 

 

3,111

 

 

 

 

 

 

(2,640

)

 

(h)

 

 

471

 

Impairment of goodwill

 

 

5,007

 

 

 

 

 

 

 

 

 

 

 

5,007

 

Impairment of intangible assets

 

 

3,633

 

 

 

 

 

 

 

 

 

 

 

3,633

 

Impairment of property and equipment

 

 

470

 

 

 

2,635

 

 

 

 

 

 

 

 

3,105

 

Loss on lease termination

 

 

3,278

 

 

 

1,044

 

 

 

 

 

 

 

 

4,322

 

Unrealized and realized foreign exchange loss

 

 

4,810

 

 

 

(262

)

 

 

 

 

 

 

 

4,548

 

Unrealized and realized loss (gain) on investments

 

 

(6,192

)

 

 

2,720

 

 

 

 

 

 

 

 

(3,472

)

Income (loss) before provision from income taxes

 

 

34,449

 

 

 

(35,490

)

 

 

(11,818

)

 

 

 

 

(12,859

)

Provision for income taxes

 

 

28,314

 

 

 

8,838

 

 

 

(3,904

)

 

(i)

 

 

33,248

 

Net income (loss)

 

$

6,135

 

 

$

(44,328

)

 

$

(7,914

)

 

 

 

$

(46,107

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation

 

 

(6,485

)

 

 

(765

)

 

 

 

 

 

 

 

(7,250

)

Comprehensive income (loss)

 

$

12,620

 

 

$

(43,563

)

 

$

(7,914

)

 

 

 

$

(38,857

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common and proportionate Shareholders of the Company

 

$

3,111

 

 

$

(18,580

)

 

$

(33,662

)

 

 

 

$

(49,131

)

Non-controlling interests

 

 

3,024

 

 

$

(25,748

)

 

$

25,748

 

 

(g)

 

 

3,024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss) attributable to:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common and proportionate Shareholders of the Company

 

$

9,596

 

 

$

(17,815

)

 

$

(33,662

)

 

 

 

$

(41,881

)

Non-controlling interests

 

 

3,024

 

 

$

(25,748

)

 

$

25,748

 

 

(g)

 

 

3,024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share, basic and diluted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share, basic

 

$

0.02

 

 

 

 

 

 

 

 

 

 

$

(0.20

)

Weighted average number of outstanding common and proportionate voting shares

 

 

181,056,654

 

 

 

 

 

 

 

 

 

 

 

245,586,756

 

Net income (loss) per share, diluted

 

$

0.01

 

 

 

 

 

 

 

 

 

 

$

(0.20

)

Weighted average number of outstanding common and proportionate voting shares, assuming dilution

 

 

208,708,664

 

 

 

 

 

 

 

 

 

 

 

245,586,756

 

 


1. Basis of presentation

The pro forma financial statements represent the combined company's (TerrAscend and Gage) pro forma balance sheet as of December 31, 2021, and pro forma statements of operations for the year ended December 31, 2021. The pro forma financial statements are based on the historical consolidated financial statements of TerrAscend and Gage, adjusted to give effect to the Gage Acquisition, and should be read in conjunction with the historical financial statements from which they are derived. The pro forma balance sheets give effect to the Gage Acquisition as if it had occurred on December 31, 2021. The pro forma statements of operations give effect to the Gage Acquisition as if it had occurred on January 1, 2021.

 

These pro forma financial statements were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Company's presentation currency is in US dollar ("USD"). All amounts are presented in USD unless otherwise specified. References to C$ are to Canadian dollars.

 

In preparing the pro forma financial statements, the following historical information was used:

Audited consolidated financial statements of TerrAscend as of December 31, 2021 as found in Form 10-K which was filed with the SEC on March 17, 2022; and
Audited financial statements of Gage for the year ended December 31, 2021, included in Exhibit 99.1 to the Company's Form 8-K/A filed with the SEC on May 24, 2022.

 

The unaudited pro forma condensed combined balance sheet and statements of operations should be read in conjunction with the historical financial statements including the notes thereto, as listed above, which are incorporated by reference.

 

The Gage Acquisition is accounted for as a business combination. The Company has estimated the fair value of Gage net assets acquired and conformed the accounting policies of Gage to its own accounting policies.

 

The pro forma financial statements have been prepared for illustrative purposes only and may not be indicative of the operating results or financial condition that would have been achieved if the Gage Acquisition had been completed on the dates or for the periods presented, nor do they purport to project the results of operations or financial position for any future period or as of any future date. The actual financial position and results of operations may differ materially from the pro forma amounts reflected herein due to a variety of factors.

 


2. Pro forma adjustments

Certain reclassifications have been made to the historical presentation of Gage to conform to the financial statement presentation of the Company, as follows:

 

 

 

As of December 31, 2021

 

Unaudited Pro Forma Combined Balance Sheet

 

Reclassification from

 

 

Reclassification to

 

Assets

 

 

 

 

 

 

Marketable securities

 

$

(565

)

 

$

-

 

Prepaid expenses and other current assets

 

 

 

 

 

565

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Property purchase payable, current

 

 

(2,665

)

 

 

 

Debentures payable

 

 

(2,804

)

 

 

 

Financing liability

 

 

(689

)

 

 

 

Other current liabilities

 

 

 

 

 

6,158

 

Property purchase payable, non-current

 

 

(3,823

)

 

 

 

Other long term liabilities

 

 

 

 

 

3,823

 

Total

 

$

(10,546

)

 

$

10,546

 

 

 

 

Year Ended December 31, 2021

 

Unaudited Pro Forma Combined Statement of Operations

 

Reclassification from

 

 

Reclassification to

 

Sales and marketing

 

$

(7,089

)

 

$

-

 

Litigation expense

 

 

(2,700

)

 

 

 

Operating lease expense

 

 

(509

)

 

 

 

General and administrative expenses

 

 

 

 

 

10,298

 

Loss on disposal of finance lease

 

 

(1,044

)

 

 

 

Loss on lease termination

 

 

 

 

 

1,044

 

Change in fair value of marketable securities

 

 

(467

)

 

 

 

Finance and other expenses

 

 

 

 

 

467

 

Change in fair value of investments

 

 

(2,720

)

 

 

 

Unrealized and realized loss (gain) on investments

 

 

 

 

 

2,720

 

(Gain) loss on financial instruments

 

 

6,231

 

 

 

 

(Gain) loss on fair value of warrants and purchase option derivative asset

 

 

 

 

 

(6,231

)

Total

 

$

(8,298

)

 

$

8,298

 

 

The following adjustments have been made to the pro forma financial statements. These adjustments reflect only preliminary purchase accounting estimates as of December 31, 2021. Fair value assessment and valuations have not yet been completed and alignment of accounting policies is still in progress and therefore not reflected herein.

a)
Reflects adjustment to record the fair value of the inventory acquired. The calculation of inventory value was estimated based on the expected selling price of the inventory, less the remaining selling costs. The pro forma statement of operations and comprehensive income (loss) for the year ended December 31, 2021 is also adjusted to increase cost of sales by the same amount since the acquired inventory is expected to be sold within one year of the acquisition date. This adjustment is not expected to have an impact on the Company's statement of operations and comprehensive income (loss) beyond twelve months after the acquisition date.
b)
Reflects adjustments to record the fair value of property and equipment acquired. The estimated fair value was estimated using a market participant approach. Additional depreciation expense of $178 was calculated as a result of the change in the value of the property and equipment. Estimated useful life to calculate depreciation expense over a straight-line basis ranged from 4 to 39 years.
c)
Reflects adjustments to record the fair value of indefinite-lived and amortizable intangible assets acquired. The acquired intangible assets include cultivation and processing licenses, as well as retail licenses, which are treated as definite-lived intangible assets and are to be amortized over a 15 year period. The fair value of the cultivation and processing and the retail licenses are $77,198 and $53,321, respectively. Amortization for the year ended December 31, 2021 was estimated to be $8,701. In addition, the intangible assets include brand intangibles which are treated as indefinite lived intangible assets with a fair value of $57,435.
d)
Reflects the preliminary estimate of goodwill, which represents the excess of the consideration transferred over the preliminary fair value of the net assets acquired.
e)
Reflects the remeasurement of the warrant liability to fair value using the Black Scholes simulation model using TerrAscend specific inputs and assumptions. Key inputs and assumptions used in the Black Scholes simulation valuation model are summarized below.

Common Stock Price of TerrAscend Corp.

 

$

6.12

 

Warrant Exercise Price

 

$

8.65

 

Annual Volatility

 

 

64.43

%

Annual Risk-Free Rate

 

 

0.73

%

Expected Term

 

2 years

 

f)
Reflects the consideration if the acquisition took place on December 31, 2021, in the form of 42,022,602 Common Shares valued at $256,968, 22,507,500 exchangeable units valued at $137,633, 4,714,132 replacement stock options and 47,727 replacement warrants with a total fair value of $16,843. Each of the directors, officers, and 10% shareholders of Gage entered into voting support and lock-up agreements in which the shares issued to these individuals are subject to various vesting periods. As such, a restriction discount of $55,941 has been placed over the shares subject to lock-up.
g)
Reflects adjustments to eliminate the historical book value of Gage's net assets, as a result of the application of purchase accounting.
h)
Reflects direct, incremental costs of the Gage Acquisition which are reflected in the historical financial statements of TerrAscend.
i)
Reflects adjustment to record the impact of the above adjustments on deferred tax liability and income tax expense. An estimated federal and state statutory tax rate of 27% was assumed for the pro forma adjustments. The blended tax rate is not necessarily indicative of the effective tax rate of the combined company. The effective tax rate of the Company could vary significantly.

 

 

 


3. Preliminary purchase price allocation

The following table summarizes the calculation of the estimated consideration (in thousands, except share and per share data):

Gage Common shares outstanding as of December 31, 2021

 

 

140,028,663

 

Gage Exchangeable Non-Voting shares outstanding as of December 31, 2021

 

 

75,000,000

 

Total Gage Shares outstanding as of December 31, 2021

 

 

215,028,663

 

Exchange Ratio

 

 

0.3001

 

TerrAscend shares issued based on Exchange Ratio1

 

 

64,530,102

 

TerrAscend share price at closing date

 

$

6.12

 

Share Consideration

 

$

394,602

 

Less: Restricted share consideration discount

 

$

(55,941

)

Fair value of share consideration

 

$

338,661

 

Fair value of other equity instruments

 

$

16,843

 

Fair value of warrants classified as liabilities

 

$

11,385

 

Total consideration

 

$

366,890

 

The following table presents the preliminary purchase price allocation of the net assets acquired as if the Gage Acquisition occurred on December 31, 2021:

 

 

$

 

Cash and cash equivalents

 

 

42,901

 

Restricted cash

 

 

1,800

 

Accounts receivable

 

 

7,700

 

Investments

 

 

2,294

 

Inventory

 

 

23,218

 

Prepaid expenses and other current assets

 

 

2,699

 

Property and equipment

 

 

69,835

 

Operating lease right of use asset

 

 

2,317

 

Deposits

 

 

1,541

 

Intangible assets

 

 

188,289

 

Goodwill

 

 

201,256

 

Accounts payable and accrued liabilities

 

 

(33,623

)

Corporate income tax payable

 

 

(4,419

)

Lease liability

 

 

(2,477

)

Deferred revenue

 

 

(583

)

Loans payable

 

 

(60,847

)

Deferred income tax liability

 

 

(50,333

)

Financing obligations

 

 

(12,235

)

Other liabilities

 

 

(10,226

)

Net assets acquired

 

 

369,107

 

 

 

 

 

Common shares of TerrAscend

 

 

340,878

 

Fair value of other equity instruments

 

 

16,843

 

Fair value of warrants classified as liabilities

 

 

11,385

 

Total consideration

 

 

369,107

 

The Company prepared the allocation of the purchase price as if the Gage Acquisition occurred on December 31, 2021 based on estimates of the fair value of the acquired assets and assumed liabilities on a basis consistent with the purchase price allocation initially recorded at the closing the Gage Acquisition. As the Company continues to obtain additional information supporting the final valuation of inventories, property, plant and equipment and intangible assets, it will refine the estimates of fair value and revise its allocation of the purchase price. The Company expects to finalize the valuation of the assets and liabilities, as well as post-closing adjustments as soon as practicable, but in any event no later than one year from the closing date of the Gage Acquisition.

The accounting for this acquisition has been provisionally determined. The fair value of net assets acquired, specifically with respect to inventory, intangible assets, deferred revenue, property and equipment, operating right of use assets, lease liabilities, investments, corporate income taxes payable, deferred tax liability, and goodwill have been determined provisionally and are subject to adjustment. Upon completion of a comprehensive valuation and finalization of the purchase price allocation, the amounts above may be adjusted


retrospectively to the acquisition date in future reporting periods.

 

 

 

 



trssf-20220308.xsd
Attachment: XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT


trssf-20220308_lab.xml
Attachment: XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT


trssf-20220308_pre.xml
Attachment: XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT